TerenceWon的个人主页 - 老虎社区

TerenceWon

TerenceWon

暂无个人介绍

IP属地：未知

30关注

1粉丝

0主题

0勋章

2021-08-02

Buy buy buy, up up up

Alibaba,Uber, DraftKings, GM, Roku, EA, ViacomCBS, and Other Stocks for Investors to Watch This Week

2021-06-15

Wait wait wait

抱歉，原内容已删除

2021-06-15

well said

Novavax Vs. Pfizer Vs. Moderna: How COVID-19 Vaccines Stack Up

2021-06-14

SS ???

2021-06-01

Great ariticle, would you like to share it?

抱歉，原内容已删除

2021-04-13

Hmm..

Toplines Before US Market Open on Tuesday

2021-04-13

Patience

Johnson & Johnson dipped about 3% in premarket trading

2021-04-11

Nice

抱歉，原内容已删除

2021-04-11

Nice

抱歉，原内容已删除

2021-04-10

Ok, not bad

抱歉，原内容已删除

2021-04-10

Why not

抱歉，原内容已删除

2021-04-10

Okay...

Next Week’s IPO Lineup Is Growing. It Could Be Busy.

2021-04-10

Well.....

Google urges U.S. to work with the EU on trade as enforcers abroad pursue regulations

2021-04-10

Ah.....

抱歉，原内容已删除

2021-04-10

Good good

抱歉，原内容已删除

2021-04-09

My fav

In Tesla's Quest For $25,000 EV, Panasonic Thinks It Has Crucial Role To Play

2021-04-09

Aduh, come on

抱歉，原内容已删除

2021-04-09

Ya, careful

抱歉，原内容已删除

2021-04-09

Lower, I want to enter

2021-04-09

No confidence

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3578819471059082","uuid":"3578819471059082","gmtCreate":1615726207139,"gmtModify":1617694737337,"name":"TerenceWon","pinyin":"terencewon","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":30,"tweetSize":28,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.08.16","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":805698753,"gmtCreate":1627873984672,"gmtModify":1633755712277,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Buy buy buy, up up up","listText":"Buy buy buy, up up up","text":"Buy buy buy, up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/805698753","repostId":"1170689665","repostType":4,"repost":{"id":"1170689665","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627857540,"share":"https://www.laohu8.com/m/news/1170689665?lang=&edition=full","pubTime":"2021-08-02 06:39","market":"us","language":"en","title":"Alibaba,Uber, DraftKings, GM, Roku, EA, ViacomCBS, and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1170689665","media":"Tiger Newspress","summary":"The parade of second-quarter results continues this week. No fewer than 143 S&P 500 companies are on deck to report, in addition to hundreds of small caps. Ferrari, Vornado Realty Trust, Take-Two Interactive Software, and Simon Property Group will get the ball rolling on Monday. Then Lyft, Alibaba Group Holding, Nikola, Under Armour, Eli Lilly, and ConocoPhillips release their results on Tuesday.Wednesday will be particularly busy:General Motors,Uber Technologies,Etsy,Electronic Arts,Western Dig","content":"<p>The parade of second-quarter results continues this week. No fewer than 143 S&amp;P 500 companies are on deck to report, in addition to hundreds of small caps. Ferrari, Vornado Realty Trust, Take-Two Interactive Software, and Simon Property Group will get the ball rolling on Monday. Then Lyft, Alibaba Group Holding, Nikola, Under Armour, Eli Lilly, and ConocoPhillips release their results on Tuesday.</p>\n<p>Wednesday will be particularly busy:General Motors,Uber Technologies,Etsy,Electronic Arts,Western Digital,Roku,CVS Health,Kraft Heinz, and SoftBank all report.Beyond Meat,Yelp,Wayfair, Moderna, and&nbsp;ViacomCBS&nbsp;go on Thursday and&nbsp;DraftKings,Canopy Growth,and Tripadvisor will close the week on Friday.Chinese Education Corporation&nbsp;New Oriental Education &amp; Technology Group Inc. and&nbsp;TAL Education Group&nbsp;cancels scheduled earnings release and earnings call.</p>\n<p><img src=\"https://static.tigerbbs.com/94057bf11ca8d7311db6c075ba98727b\" tg-width=\"1706\" tg-height=\"740\" referrerpolicy=\"no-referrer\"></p>\n<p>The highlight on the&nbsp;economic&nbsp;calendar this week will be Jobs Friday. The Bureau of Labor Statistics is expected to show a gain of 625,000 nonfarm payrolls in July, following June’s 850,000. The unemployment rate is seen holding just below 6%.</p>\n<p>Other data out this week include the Institute for Supply Management’s Manufacturing Purchasing Managers’ Index for July on Monday, followed by the Services equivalent on Wednesday. Both measures of economic activity are forecast to come in at around 61, which would signify strong expansion.</p>\n<p><b>Monday 8/2</b></p>\n<p>CNA Financial,Global Payments,JELD-WEN Holding,Loews,Arista Networks,Leggett &amp; Platt,Vornado Realty Trust, ZoomInfo Technologies, Woodward, Take-Two Interactive Software, Heineken, Trex, Ferrari,Ultra Clean Holdings,and Simon Property Group are expected to release financial results.</p>\n<p>GE stock&nbsp;will open for trading Monday at about $104 a share, after closing Friday at $12.95. The company completed its 1-for-8 reverse stock split Friday evening.</p>\n<p><b>The Institute for Supply</b>&nbsp;Management releases its Manufacturing Purchasing Managers’ Index for July. Consensus estimate is for a 60.8 reading, up from 60.6 in June.</p>\n<p><b>The Census Bureau</b>&nbsp;reports construction spending for June. Expectations are for a 0.4% month-over-month rise, after a 0.3% decline in May.</p>\n<p><b>Tuesday 8/3</b></p>\n<p>Eaton, BP, Under Armour, Lyft,Clorox,Amgen,Akamai Technologies,Cummins, Eli Lilly, Alibaba Group Holding, Nikola, EnPro Industries,Warner Music Group,Pitney Bowes,Tennant,Phillips 66,KKR,Gartner,Henry Schein,Dun &amp; Bradstreet Holdings,ConocoPhillips, and&nbsp;Jacobs Engineering Grouphost conference calls to discuss financial results.</p>\n<p><b>The Census Bureau</b>&nbsp;is slated to report factory orders for June. Economists predict that orders increased 1.0% during the month, compared with a 1.7% rise in May.</p>\n<p><b>Wednesday 8/4</b></p>\n<p>Sony Group,CVS Health, Kraft Heinz, SoftBank, General Motors, Progressive, Etsy, Electronic Arts, Western Digital, Uber Technologies, Roku,MGM Resorts International,Fox, and Re/Max Holdings are expected to host earnings calls.</p>\n<p><b>The Bureau of Economic</b>&nbsp;Analysis reports light-vehicle sales for July. Expectations call for a seasonally adjusted annual rate of 15.3 million vehicles, versus 15.4 million in June.</p>\n<p><b>The ISM releases</b>&nbsp;its Services PMI for July. Consensus estimate is for a 60.8 reading, compared with June’s 60.1.</p>\n<p><b>ADP releases</b>&nbsp;its National Employment report for July. Consensus estimate is for a 635,000 gain in nonfarm private-sector employment, following an increase of 692,000 in June.</p>\n<p><b>Thursday 8/5</b></p>\n<p>Zillow Group,Beyond Meat, Yelp, Wayfair, Kellogg,Bayer,HanesBrands, Moderna,Regeneron Pharmaceuticals,Switch,Cushman &amp; Wakefield,ViacomCBS,Cigna,Duke Energy,Square,News Corp,and&nbsp;Siemensare expected to report financial results.</p>\n<p>Friday 8/6</p>\n<p><b>The BLS releases the jobs report</b>&nbsp;for July. Economists forecast a 800,000 rise in nonfarm payrolls, after an 850,000 gain in June. The unemployment rate is expected to edge down to 5.8% from 5.9%.</p>\n<p>DraftKings,Dominion Energy,Gannett,MGM Growth Properties,AMC Networks,Canopy Growth, Tripadvisor,Spectrum Brands Holdings,E.W. Scripps,Cinemark Holdings, and Manitowoc host conference calls to discuss financial results.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba,Uber, DraftKings, GM, Roku, EA, ViacomCBS, and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba,Uber, DraftKings, GM, Roku, EA, ViacomCBS, and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-02 06:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The parade of second-quarter results continues this week. No fewer than 143 S&amp;P 500 companies are on deck to report, in addition to hundreds of small caps. Ferrari, Vornado Realty Trust, Take-Two Interactive Software, and Simon Property Group will get the ball rolling on Monday. Then Lyft, Alibaba Group Holding, Nikola, Under Armour, Eli Lilly, and ConocoPhillips release their results on Tuesday.</p>\n<p>Wednesday will be particularly busy:General Motors,Uber Technologies,Etsy,Electronic Arts,Western Digital,Roku,CVS Health,Kraft Heinz, and SoftBank all report.Beyond Meat,Yelp,Wayfair, Moderna, and&nbsp;ViacomCBS&nbsp;go on Thursday and&nbsp;DraftKings,Canopy Growth,and Tripadvisor will close the week on Friday.Chinese Education Corporation&nbsp;New Oriental Education &amp; Technology Group Inc. and&nbsp;TAL Education Group&nbsp;cancels scheduled earnings release and earnings call.</p>\n<p><img src=\"https://static.tigerbbs.com/94057bf11ca8d7311db6c075ba98727b\" tg-width=\"1706\" tg-height=\"740\" referrerpolicy=\"no-referrer\"></p>\n<p>The highlight on the&nbsp;economic&nbsp;calendar this week will be Jobs Friday. The Bureau of Labor Statistics is expected to show a gain of 625,000 nonfarm payrolls in July, following June’s 850,000. The unemployment rate is seen holding just below 6%.</p>\n<p>Other data out this week include the Institute for Supply Management’s Manufacturing Purchasing Managers’ Index for July on Monday, followed by the Services equivalent on Wednesday. Both measures of economic activity are forecast to come in at around 61, which would signify strong expansion.</p>\n<p><b>Monday 8/2</b></p>\n<p>CNA Financial,Global Payments,JELD-WEN Holding,Loews,Arista Networks,Leggett &amp; Platt,Vornado Realty Trust, ZoomInfo Technologies, Woodward, Take-Two Interactive Software, Heineken, Trex, Ferrari,Ultra Clean Holdings,and Simon Property Group are expected to release financial results.</p>\n<p>GE stock&nbsp;will open for trading Monday at about $104 a share, after closing Friday at $12.95. The company completed its 1-for-8 reverse stock split Friday evening.</p>\n<p><b>The Institute for Supply</b>&nbsp;Management releases its Manufacturing Purchasing Managers’ Index for July. Consensus estimate is for a 60.8 reading, up from 60.6 in June.</p>\n<p><b>The Census Bureau</b>&nbsp;reports construction spending for June. Expectations are for a 0.4% month-over-month rise, after a 0.3% decline in May.</p>\n<p><b>Tuesday 8/3</b></p>\n<p>Eaton, BP, Under Armour, Lyft,Clorox,Amgen,Akamai Technologies,Cummins, Eli Lilly, Alibaba Group Holding, Nikola, EnPro Industries,Warner Music Group,Pitney Bowes,Tennant,Phillips 66,KKR,Gartner,Henry Schein,Dun &amp; Bradstreet Holdings,ConocoPhillips, and&nbsp;Jacobs Engineering Grouphost conference calls to discuss financial results.</p>\n<p><b>The Census Bureau</b>&nbsp;is slated to report factory orders for June. Economists predict that orders increased 1.0% during the month, compared with a 1.7% rise in May.</p>\n<p><b>Wednesday 8/4</b></p>\n<p>Sony Group,CVS Health, Kraft Heinz, SoftBank, General Motors, Progressive, Etsy, Electronic Arts, Western Digital, Uber Technologies, Roku,MGM Resorts International,Fox, and Re/Max Holdings are expected to host earnings calls.</p>\n<p><b>The Bureau of Economic</b>&nbsp;Analysis reports light-vehicle sales for July. Expectations call for a seasonally adjusted annual rate of 15.3 million vehicles, versus 15.4 million in June.</p>\n<p><b>The ISM releases</b>&nbsp;its Services PMI for July. Consensus estimate is for a 60.8 reading, compared with June’s 60.1.</p>\n<p><b>ADP releases</b>&nbsp;its National Employment report for July. Consensus estimate is for a 635,000 gain in nonfarm private-sector employment, following an increase of 692,000 in June.</p>\n<p><b>Thursday 8/5</b></p>\n<p>Zillow Group,Beyond Meat, Yelp, Wayfair, Kellogg,Bayer,HanesBrands, Moderna,Regeneron Pharmaceuticals,Switch,Cushman &amp; Wakefield,ViacomCBS,Cigna,Duke Energy,Square,News Corp,and&nbsp;Siemensare expected to report financial results.</p>\n<p>Friday 8/6</p>\n<p><b>The BLS releases the jobs report</b>&nbsp;for July. Economists forecast a 800,000 rise in nonfarm payrolls, after an 850,000 gain in June. The unemployment rate is expected to edge down to 5.8% from 5.9%.</p>\n<p>DraftKings,Dominion Energy,Gannett,MGM Growth Properties,AMC Networks,Canopy Growth, Tripadvisor,Spectrum Brands Holdings,E.W. Scripps,Cinemark Holdings, and Manitowoc host conference calls to discuss financial results.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170689665","content_text":"The parade of second-quarter results continues this week. No fewer than 143 S&P 500 companies are on deck to report, in addition to hundreds of small caps. Ferrari, Vornado Realty Trust, Take-Two Interactive Software, and Simon Property Group will get the ball rolling on Monday. Then Lyft, Alibaba Group Holding, Nikola, Under Armour, Eli Lilly, and ConocoPhillips release their results on Tuesday.\nWednesday will be particularly busy:General Motors,Uber Technologies,Etsy,Electronic Arts,Western Digital,Roku,CVS Health,Kraft Heinz, and SoftBank all report.Beyond Meat,Yelp,Wayfair, Moderna, and ViacomCBS go on Thursday and DraftKings,Canopy Growth,and Tripadvisor will close the week on Friday.Chinese Education Corporation New Oriental Education & Technology Group Inc. and TAL Education Group cancels scheduled earnings release and earnings call.\n\nThe highlight on the economic calendar this week will be Jobs Friday. The Bureau of Labor Statistics is expected to show a gain of 625,000 nonfarm payrolls in July, following June’s 850,000. The unemployment rate is seen holding just below 6%.\nOther data out this week include the Institute for Supply Management’s Manufacturing Purchasing Managers’ Index for July on Monday, followed by the Services equivalent on Wednesday. Both measures of economic activity are forecast to come in at around 61, which would signify strong expansion.\nMonday 8/2\nCNA Financial,Global Payments,JELD-WEN Holding,Loews,Arista Networks,Leggett & Platt,Vornado Realty Trust, ZoomInfo Technologies, Woodward, Take-Two Interactive Software, Heineken, Trex, Ferrari,Ultra Clean Holdings,and Simon Property Group are expected to release financial results.\nGE stock will open for trading Monday at about $104 a share, after closing Friday at $12.95. The company completed its 1-for-8 reverse stock split Friday evening.\nThe Institute for Supply Management releases its Manufacturing Purchasing Managers’ Index for July. Consensus estimate is for a 60.8 reading, up from 60.6 in June.\nThe Census Bureau reports construction spending for June. Expectations are for a 0.4% month-over-month rise, after a 0.3% decline in May.\nTuesday 8/3\nEaton, BP, Under Armour, Lyft,Clorox,Amgen,Akamai Technologies,Cummins, Eli Lilly, Alibaba Group Holding, Nikola, EnPro Industries,Warner Music Group,Pitney Bowes,Tennant,Phillips 66,KKR,Gartner,Henry Schein,Dun & Bradstreet Holdings,ConocoPhillips, and Jacobs Engineering Grouphost conference calls to discuss financial results.\nThe Census Bureau is slated to report factory orders for June. Economists predict that orders increased 1.0% during the month, compared with a 1.7% rise in May.\nWednesday 8/4\nSony Group,CVS Health, Kraft Heinz, SoftBank, General Motors, Progressive, Etsy, Electronic Arts, Western Digital, Uber Technologies, Roku,MGM Resorts International,Fox, and Re/Max Holdings are expected to host earnings calls.\nThe Bureau of Economic Analysis reports light-vehicle sales for July. Expectations call for a seasonally adjusted annual rate of 15.3 million vehicles, versus 15.4 million in June.\nThe ISM releases its Services PMI for July. Consensus estimate is for a 60.8 reading, compared with June’s 60.1.\nADP releases its National Employment report for July. Consensus estimate is for a 635,000 gain in nonfarm private-sector employment, following an increase of 692,000 in June.\nThursday 8/5\nZillow Group,Beyond Meat, Yelp, Wayfair, Kellogg,Bayer,HanesBrands, Moderna,Regeneron Pharmaceuticals,Switch,Cushman & Wakefield,ViacomCBS,Cigna,Duke Energy,Square,News Corp,and Siemensare expected to report financial results.\nFriday 8/6\nThe BLS releases the jobs report for July. Economists forecast a 800,000 rise in nonfarm payrolls, after an 850,000 gain in June. The unemployment rate is expected to edge down to 5.8% from 5.9%.\nDraftKings,Dominion Energy,Gannett,MGM Growth Properties,AMC Networks,Canopy Growth, Tripadvisor,Spectrum Brands Holdings,E.W. Scripps,Cinemark Holdings, and Manitowoc host conference calls to discuss financial results.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"BABA":0.9,"DKNG":0.9,"EA":0.9,"GE":0.9,"GM":0.9,"ROKU":0.9,"UBER":0.9,"VIAC":0.9}},"isVote":1,"tweetType":1,"viewCount":1466,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187248023,"gmtCreate":1623756784062,"gmtModify":1634028927678,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Wait wait wait","listText":"Wait wait wait","text":"Wait wait wait","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/187248023","repostId":"1193728447","repostType":4,"isVote":1,"tweetType":1,"viewCount":1247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187243511,"gmtCreate":1623756736633,"gmtModify":1634028928989,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"well said","listText":"well said","text":"well said","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/187243511","repostId":"1167457915","repostType":4,"repost":{"id":"1167457915","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1623750756,"share":"https://www.laohu8.com/m/news/1167457915?lang=&edition=full","pubTime":"2021-06-15 17:52","market":"us","language":"en","title":"Novavax Vs. Pfizer Vs. Moderna: How COVID-19 Vaccines Stack Up","url":"https://stock-news.laohu8.com/highlight/detail?id=1167457915","media":"Benzinga","summary":"It was \"better late than never\" for Novavax, Inc.NVAX, as the biopharma finally got around to announ","content":"<p>It was \"better late than never\" for&nbsp;<b>Novavax, Inc.</b>NVAX, as the biopharma finally got around to announcing interim results from the U.S. and Mexico leg of the Phase 3 study of NVX-CoV2371, its vaccine candidate against the novel coronavirus.</p>\n<p>Here's a comparative perspective of the vaccine candidates from Novavax, and the frontrunners, namely<b>Pfizer Inc.</b>PFE 0.05%-<b>BioNTech SE</b>BNTXand<b>Moderna, Inc.</b>MRNA, both of which have authorized vaccines in the market.</p>\n<p><b>Vaccine Type:</b>&nbsp;Novavax's NVX-CoV2371 is a recombinant nano-particle protein-based COVID-19 vaccine that is packaged with the company's proprietary Matrix-M adjuvant.</p>\n<p>The Pfizer-BioNTech and Moderna products are mRNA vaccines, or modern&nbsp;vaccines that work by using a genetic code called mRNA that instructs our immune cells to make spike protein, which is found on the surface of the virus that causes COVID-19.</p>\n<p>This spike protein, though harmless, is capable of triggering our immune system to produce antibodies that offer protection against future infection.</p>\n<p>Novavax's vaccine is a protein adjuvant that contains the spike protein of the coronavirus itself, but formulated as a nanoparticle&nbsp;that cannot cause disease. The injected vaccine then stimulates the immune system to produce antibodies and T-cell immune responses.</p>\n<p><b>The Vaccine Doses:</b>&nbsp;The vaccines from each of the three companies require two doses. Each dose consists of 30 mcg for Pfizer and 100 mcg for Moderna, while for Novavax, each vaccine dose consists of 5 mcg of NVX-CoV2371 and 50 mcg of Matrix-M1 adjuvant that are co-formulated.</p>\n<p>The interval between the two doses —&nbsp;the priming and booster dose —&nbsp;is 21 days each for Pfizer and Novavax and 28 days for Moderna.</p>\n<p><b>The Target Population:</b>&nbsp;The original late-stage trial of Pfizer-BioNTech evaluated the vaccine in participants&nbsp;ages 16 years and older. The trial enrolled 43,448 participants.</p>\n<p>Moderna'sPhase 3 COVE study enrolled 30,000 participants&nbsp;ages 18 years and up.</p>\n<p>Since then, these two companies have obtained authorizations for their respective vaccines to be used in adolescents.</p>\n<p>Bothcompanieshave also initiated studies in the pediatric population.</p>\n<p>Novavax's study enrolled 29,960 participants&nbsp;18 years of age and older&nbsp;across 119 sites in the U.S. and Mexico. The placebo-controlled portion of PREVENT-19 continues in adolescents from 12 to less than 18 years of age and recently completed enrollment with 2,248 participants.</p>\n<p><b>Vaccine Logistics:</b>&nbsp;Pfizer recently secured FDA authorization for storing undiluted, thawed vaccine vials in the refrigerator at 2°C to 8°C for up to one month.</p>\n<p>Previously, thawed, undiluted vaccine vials could be stored in the refrigerator for up to five&nbsp;days. Moderna's vaccine can be stored refrigerated between 2° and 8°C for up to 30 days prior to first use.</p>\n<p>NVX-CoV2373 is stored and stable at 2°- 8°C, allowing the use of existing vaccine supply chain channels for its distribution. It is packaged in a ready-to-use liquid formulation in 10-dose vials.</p>\n<p><b>Vaccine Efficacy:</b>&nbsp;Interim data from Pfizer-BioNTech's Phase 3 trials released in December showed the vaccine was well-tolerated and demonstrated 95% efficacy in preventing COVID-19 in those without prior infection seven&nbsp;days or more after the second dose. Updated top-line results released for up to six months after the second dose confirmed efficacy at 91.3%.</p>\n<p>The vaccine was found 100% effective against severe disease as defined by the U.S. Centers for Disease Control and Prevention, and 95.3% effective against severe COVID-19 as defined by the FDA. It was also proved effective against the U.K. strain in lab studies.</p>\n<p>Moderna's vaccine showed efficacy of 94.1% against COVID-19. The company announced in May initial data from its Phase 2 study showing that a single 50 mcg dose of mRNA-1273 or mRNA-1273.351 given as a booster to previously vaccinated individuals increased neutralizing antibody titer responses against SARS-CoV-2 and two variants of concern, B.1.351, first identified in South Africa, and P.1, first identified in Brazil.</p>\n<p>Novavax's investigational vaccine demonstrated 100% protection against moderate and severe disease not involving variants of concern or variants of interest.</p>\n<p>Against variants of concern and variants of interest, the efficacy was 93.2% and in high-risk populations, defined as over 65 or under 65 years with certain comorbidities or having circumstances with frequent COVID-19 exposure, the efficacy was 91%.</p>\n<p>Overall efficacy was 90.4%, meeting the primary endpoint.</p>\n<p><b>Cantor Fitzgerald On Novavax's Vaccine:</b>A differentiating factor for NVX-2373&nbsp;is that it showed vaccine efficacy of 93.2% against VoC/VoI, which demonstrates protection across a broad range of SARS-CoV-2 strains, Cantor Fitzgerald analyst Charles Duncan said in a Monday morning note.</p>\n<p>\"Overall, these results enhance our conviction for a differentiated clinical and logistics profile from the SARS-CoV-2 vaccine candidate ‘2373,\" the analyst said.</p>\n<p>Showing efficacy against new strains in two Phase 3 clinical trials, rather than extrapolating potential efficacy from a neutralizing antibody assay conducted in a petri dish, differentiates NVX-CoV2373 from other vaccines that have emergency use authorization, he said.</p>\n<p>This profile, according to Cantor reduces regulatory/ commercial risk for the ‘2373 SARS-CoV-2 prophylactic vaccine candidate and, with positive Phase 3 data for NanoFlu reported in March 2020, should raise the profile for Novavax's platform as a whole.</p>\n<p><b>Vaccine Safety Data:</b>Pfizer-BioNTech's vaccine showed a favorable tolerability and safety profile, with the most common adverse events from&nbsp;BNT162b2 being transient, mild to moderate pain at the injection site, fatigue and headache, and these generally resolved within two days.</p>\n<p>For Moderna, the most common adverse reactions included injection site pain, fatigue, myalgia, arthralgia, headache, and erythema/redness at the injection site. Solicited adverse reactions increased in frequency and severity in the mRNA-1273 group after the second dose.</p>\n<p>Preliminary safety data from Novavax's trial showed the vaccine to be generally well-tolerated. Serious and severe adverse events were low in number and balanced between vaccine and placebo groups.</p>\n<p>In assessing reactogenicity seven&nbsp;days after dose one&nbsp;and dose two, injection site pain and tenderness, generally mild to moderate in severity, were the most common local symptoms, lasting less than three days. Fatigue, headache and muscle pain were the most common systemic symptoms, lasting less than two days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Vs. Pfizer Vs. Moderna: How COVID-19 Vaccines Stack Up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Vs. Pfizer Vs. Moderna: How COVID-19 Vaccines Stack Up\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-06-15 17:52</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>It was \"better late than never\" for&nbsp;<b>Novavax, Inc.</b>NVAX, as the biopharma finally got around to announcing interim results from the U.S. and Mexico leg of the Phase 3 study of NVX-CoV2371, its vaccine candidate against the novel coronavirus.</p>\n<p>Here's a comparative perspective of the vaccine candidates from Novavax, and the frontrunners, namely<b>Pfizer Inc.</b>PFE 0.05%-<b>BioNTech SE</b>BNTXand<b>Moderna, Inc.</b>MRNA, both of which have authorized vaccines in the market.</p>\n<p><b>Vaccine Type:</b>&nbsp;Novavax's NVX-CoV2371 is a recombinant nano-particle protein-based COVID-19 vaccine that is packaged with the company's proprietary Matrix-M adjuvant.</p>\n<p>The Pfizer-BioNTech and Moderna products are mRNA vaccines, or modern&nbsp;vaccines that work by using a genetic code called mRNA that instructs our immune cells to make spike protein, which is found on the surface of the virus that causes COVID-19.</p>\n<p>This spike protein, though harmless, is capable of triggering our immune system to produce antibodies that offer protection against future infection.</p>\n<p>Novavax's vaccine is a protein adjuvant that contains the spike protein of the coronavirus itself, but formulated as a nanoparticle&nbsp;that cannot cause disease. The injected vaccine then stimulates the immune system to produce antibodies and T-cell immune responses.</p>\n<p><b>The Vaccine Doses:</b>&nbsp;The vaccines from each of the three companies require two doses. Each dose consists of 30 mcg for Pfizer and 100 mcg for Moderna, while for Novavax, each vaccine dose consists of 5 mcg of NVX-CoV2371 and 50 mcg of Matrix-M1 adjuvant that are co-formulated.</p>\n<p>The interval between the two doses —&nbsp;the priming and booster dose —&nbsp;is 21 days each for Pfizer and Novavax and 28 days for Moderna.</p>\n<p><b>The Target Population:</b>&nbsp;The original late-stage trial of Pfizer-BioNTech evaluated the vaccine in participants&nbsp;ages 16 years and older. The trial enrolled 43,448 participants.</p>\n<p>Moderna'sPhase 3 COVE study enrolled 30,000 participants&nbsp;ages 18 years and up.</p>\n<p>Since then, these two companies have obtained authorizations for their respective vaccines to be used in adolescents.</p>\n<p>Bothcompanieshave also initiated studies in the pediatric population.</p>\n<p>Novavax's study enrolled 29,960 participants&nbsp;18 years of age and older&nbsp;across 119 sites in the U.S. and Mexico. The placebo-controlled portion of PREVENT-19 continues in adolescents from 12 to less than 18 years of age and recently completed enrollment with 2,248 participants.</p>\n<p><b>Vaccine Logistics:</b>&nbsp;Pfizer recently secured FDA authorization for storing undiluted, thawed vaccine vials in the refrigerator at 2°C to 8°C for up to one month.</p>\n<p>Previously, thawed, undiluted vaccine vials could be stored in the refrigerator for up to five&nbsp;days. Moderna's vaccine can be stored refrigerated between 2° and 8°C for up to 30 days prior to first use.</p>\n<p>NVX-CoV2373 is stored and stable at 2°- 8°C, allowing the use of existing vaccine supply chain channels for its distribution. It is packaged in a ready-to-use liquid formulation in 10-dose vials.</p>\n<p><b>Vaccine Efficacy:</b>&nbsp;Interim data from Pfizer-BioNTech's Phase 3 trials released in December showed the vaccine was well-tolerated and demonstrated 95% efficacy in preventing COVID-19 in those without prior infection seven&nbsp;days or more after the second dose. Updated top-line results released for up to six months after the second dose confirmed efficacy at 91.3%.</p>\n<p>The vaccine was found 100% effective against severe disease as defined by the U.S. Centers for Disease Control and Prevention, and 95.3% effective against severe COVID-19 as defined by the FDA. It was also proved effective against the U.K. strain in lab studies.</p>\n<p>Moderna's vaccine showed efficacy of 94.1% against COVID-19. The company announced in May initial data from its Phase 2 study showing that a single 50 mcg dose of mRNA-1273 or mRNA-1273.351 given as a booster to previously vaccinated individuals increased neutralizing antibody titer responses against SARS-CoV-2 and two variants of concern, B.1.351, first identified in South Africa, and P.1, first identified in Brazil.</p>\n<p>Novavax's investigational vaccine demonstrated 100% protection against moderate and severe disease not involving variants of concern or variants of interest.</p>\n<p>Against variants of concern and variants of interest, the efficacy was 93.2% and in high-risk populations, defined as over 65 or under 65 years with certain comorbidities or having circumstances with frequent COVID-19 exposure, the efficacy was 91%.</p>\n<p>Overall efficacy was 90.4%, meeting the primary endpoint.</p>\n<p><b>Cantor Fitzgerald On Novavax's Vaccine:</b>A differentiating factor for NVX-2373&nbsp;is that it showed vaccine efficacy of 93.2% against VoC/VoI, which demonstrates protection across a broad range of SARS-CoV-2 strains, Cantor Fitzgerald analyst Charles Duncan said in a Monday morning note.</p>\n<p>\"Overall, these results enhance our conviction for a differentiated clinical and logistics profile from the SARS-CoV-2 vaccine candidate ‘2373,\" the analyst said.</p>\n<p>Showing efficacy against new strains in two Phase 3 clinical trials, rather than extrapolating potential efficacy from a neutralizing antibody assay conducted in a petri dish, differentiates NVX-CoV2373 from other vaccines that have emergency use authorization, he said.</p>\n<p>This profile, according to Cantor reduces regulatory/ commercial risk for the ‘2373 SARS-CoV-2 prophylactic vaccine candidate and, with positive Phase 3 data for NanoFlu reported in March 2020, should raise the profile for Novavax's platform as a whole.</p>\n<p><b>Vaccine Safety Data:</b>Pfizer-BioNTech's vaccine showed a favorable tolerability and safety profile, with the most common adverse events from&nbsp;BNT162b2 being transient, mild to moderate pain at the injection site, fatigue and headache, and these generally resolved within two days.</p>\n<p>For Moderna, the most common adverse reactions included injection site pain, fatigue, myalgia, arthralgia, headache, and erythema/redness at the injection site. Solicited adverse reactions increased in frequency and severity in the mRNA-1273 group after the second dose.</p>\n<p>Preliminary safety data from Novavax's trial showed the vaccine to be generally well-tolerated. Serious and severe adverse events were low in number and balanced between vaccine and placebo groups.</p>\n<p>In assessing reactogenicity seven&nbsp;days after dose one&nbsp;and dose two, injection site pain and tenderness, generally mild to moderate in severity, were the most common local symptoms, lasting less than three days. Fatigue, headache and muscle pain were the most common systemic symptoms, lasting less than two days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167457915","content_text":"It was \"better late than never\" for Novavax, Inc.NVAX, as the biopharma finally got around to announcing interim results from the U.S. and Mexico leg of the Phase 3 study of NVX-CoV2371, its vaccine candidate against the novel coronavirus.\nHere's a comparative perspective of the vaccine candidates from Novavax, and the frontrunners, namelyPfizer Inc.PFE 0.05%-BioNTech SEBNTXandModerna, Inc.MRNA, both of which have authorized vaccines in the market.\nVaccine Type: Novavax's NVX-CoV2371 is a recombinant nano-particle protein-based COVID-19 vaccine that is packaged with the company's proprietary Matrix-M adjuvant.\nThe Pfizer-BioNTech and Moderna products are mRNA vaccines, or modern vaccines that work by using a genetic code called mRNA that instructs our immune cells to make spike protein, which is found on the surface of the virus that causes COVID-19.\nThis spike protein, though harmless, is capable of triggering our immune system to produce antibodies that offer protection against future infection.\nNovavax's vaccine is a protein adjuvant that contains the spike protein of the coronavirus itself, but formulated as a nanoparticle that cannot cause disease. The injected vaccine then stimulates the immune system to produce antibodies and T-cell immune responses.\nThe Vaccine Doses: The vaccines from each of the three companies require two doses. Each dose consists of 30 mcg for Pfizer and 100 mcg for Moderna, while for Novavax, each vaccine dose consists of 5 mcg of NVX-CoV2371 and 50 mcg of Matrix-M1 adjuvant that are co-formulated.\nThe interval between the two doses — the priming and booster dose — is 21 days each for Pfizer and Novavax and 28 days for Moderna.\nThe Target Population: The original late-stage trial of Pfizer-BioNTech evaluated the vaccine in participants ages 16 years and older. The trial enrolled 43,448 participants.\nModerna'sPhase 3 COVE study enrolled 30,000 participants ages 18 years and up.\nSince then, these two companies have obtained authorizations for their respective vaccines to be used in adolescents.\nBothcompanieshave also initiated studies in the pediatric population.\nNovavax's study enrolled 29,960 participants 18 years of age and older across 119 sites in the U.S. and Mexico. The placebo-controlled portion of PREVENT-19 continues in adolescents from 12 to less than 18 years of age and recently completed enrollment with 2,248 participants.\nVaccine Logistics: Pfizer recently secured FDA authorization for storing undiluted, thawed vaccine vials in the refrigerator at 2°C to 8°C for up to one month.\nPreviously, thawed, undiluted vaccine vials could be stored in the refrigerator for up to five days. Moderna's vaccine can be stored refrigerated between 2° and 8°C for up to 30 days prior to first use.\nNVX-CoV2373 is stored and stable at 2°- 8°C, allowing the use of existing vaccine supply chain channels for its distribution. It is packaged in a ready-to-use liquid formulation in 10-dose vials.\nVaccine Efficacy: Interim data from Pfizer-BioNTech's Phase 3 trials released in December showed the vaccine was well-tolerated and demonstrated 95% efficacy in preventing COVID-19 in those without prior infection seven days or more after the second dose. Updated top-line results released for up to six months after the second dose confirmed efficacy at 91.3%.\nThe vaccine was found 100% effective against severe disease as defined by the U.S. Centers for Disease Control and Prevention, and 95.3% effective against severe COVID-19 as defined by the FDA. It was also proved effective against the U.K. strain in lab studies.\nModerna's vaccine showed efficacy of 94.1% against COVID-19. The company announced in May initial data from its Phase 2 study showing that a single 50 mcg dose of mRNA-1273 or mRNA-1273.351 given as a booster to previously vaccinated individuals increased neutralizing antibody titer responses against SARS-CoV-2 and two variants of concern, B.1.351, first identified in South Africa, and P.1, first identified in Brazil.\nNovavax's investigational vaccine demonstrated 100% protection against moderate and severe disease not involving variants of concern or variants of interest.\nAgainst variants of concern and variants of interest, the efficacy was 93.2% and in high-risk populations, defined as over 65 or under 65 years with certain comorbidities or having circumstances with frequent COVID-19 exposure, the efficacy was 91%.\nOverall efficacy was 90.4%, meeting the primary endpoint.\nCantor Fitzgerald On Novavax's Vaccine:A differentiating factor for NVX-2373 is that it showed vaccine efficacy of 93.2% against VoC/VoI, which demonstrates protection across a broad range of SARS-CoV-2 strains, Cantor Fitzgerald analyst Charles Duncan said in a Monday morning note.\n\"Overall, these results enhance our conviction for a differentiated clinical and logistics profile from the SARS-CoV-2 vaccine candidate ‘2373,\" the analyst said.\nShowing efficacy against new strains in two Phase 3 clinical trials, rather than extrapolating potential efficacy from a neutralizing antibody assay conducted in a petri dish, differentiates NVX-CoV2373 from other vaccines that have emergency use authorization, he said.\nThis profile, according to Cantor reduces regulatory/ commercial risk for the ‘2373 SARS-CoV-2 prophylactic vaccine candidate and, with positive Phase 3 data for NanoFlu reported in March 2020, should raise the profile for Novavax's platform as a whole.\nVaccine Safety Data:Pfizer-BioNTech's vaccine showed a favorable tolerability and safety profile, with the most common adverse events from BNT162b2 being transient, mild to moderate pain at the injection site, fatigue and headache, and these generally resolved within two days.\nFor Moderna, the most common adverse reactions included injection site pain, fatigue, myalgia, arthralgia, headache, and erythema/redness at the injection site. Solicited adverse reactions increased in frequency and severity in the mRNA-1273 group after the second dose.\nPreliminary safety data from Novavax's trial showed the vaccine to be generally well-tolerated. Serious and severe adverse events were low in number and balanced between vaccine and placebo groups.\nIn assessing reactogenicity seven days after dose one and dose two, injection site pain and tenderness, generally mild to moderate in severity, were the most common local symptoms, lasting less than three days. Fatigue, headache and muscle pain were the most common systemic symptoms, lasting less than two days.","news_type":1,"symbols_score_info":{"MRNA":0.9,"NVAX":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1572,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185737575,"gmtCreate":1623672919397,"gmtModify":1634030304131,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"SS ???","listText":"SS ???","text":"SS ???","images":[{"img":"https://static.tigerbbs.com/6f51967c7d0800938abf4d9b95e60af8","width":"1080","height":"2650"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/185737575","isVote":1,"tweetType":1,"viewCount":1972,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":110434977,"gmtCreate":1622479080999,"gmtModify":1634101194889,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/110434977","repostId":"1112383458","repostType":2,"isVote":1,"tweetType":1,"viewCount":982,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345232604,"gmtCreate":1618317051208,"gmtModify":1634293769627,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Hmm..&nbsp;","listText":"Hmm..&nbsp;","text":"Hmm..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/345232604","repostId":"1179268763","repostType":4,"repost":{"id":"1179268763","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1618315607,"share":"https://www.laohu8.com/m/news/1179268763?lang=&edition=full","pubTime":"2021-04-13 20:06","market":"us","language":"en","title":"Toplines Before US Market Open on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1179268763","media":"Tiger Newspress","summary":"Stock futures drop after US officials call for pause of J&J vaccine rollout. In addition, markets lo","content":"<ul><li>Stock futures drop after US officials call for pause of J&amp;J vaccine rollout.&nbsp;</li><li>In&nbsp;addition,&nbsp;markets look to key U.S. inflation data.</li><li>The benchmark 10-year Treasury yield inched closer to 1.7%.</li><li>Bitcoin set new record, trading above $63,000.</li><li>Altimeter Growth, Johnson &amp; Johnson, FedEx &amp; more making the biggest moves in the premarket</li></ul><p>(April 13)&nbsp;Stock futures sank Tuesday morning after U.S. federal health officials called for a pause in the rollout of Johnson &amp; Johnson's (JNJ) COVID-19 vaccine amid concerns over rare blood clots in some individuals who received the inoculation.</p><p>At 8:05 a.m. ET, Dow E-minis were down 110 points, or 0.33%, S&amp;P 500 E-minis were down 10.5 points, or 0.25% and Nasdaq 100 E-minis were down 6.5&nbsp;points, or 0.05%.</p><p><img src=\"https://static.tigerbbs.com/fec9ca3c4d5c22a6aabf5a7bd8286a08\" tg-width=\"1242\" tg-height=\"492\" referrerpolicy=\"no-referrer\"></p><p>The benchmark 10-year Treasury yield inched closer to 1.7% before the Labor Department’s data that is expected to show U.S. consumer prices rose 0.5% in March from 0.4% in February. The report is due at 8:30 a.m. ET (1230 GMT).</p><p>Among stocks, U.S.-listed shares of e-commerce firm JD.com and search giant Baidu fell about 2% each in premarket trading as China’s market regulator warned internet companies to stop using any banned practices.</p><p><img src=\"https://static.tigerbbs.com/57e53e80a4150ceca7c4290b9a0e14ce\" tg-width=\"282\" tg-height=\"80\" referrerpolicy=\"no-referrer\"></p><p>Cryptocurrency and blockchain-related firms including Riot Blockchain and Marathon Digital Holdings jumped 9% and 8% as bitcoin prices soared 4.5%, a day ahead of listing of Coinbase, the largest U.S. cryptocurrency exchange.</p><p><img src=\"https://static.tigerbbs.com/759502388fc3c70949384c724fa01051\" tg-width=\"292\" tg-height=\"355\" referrerpolicy=\"no-referrer\"></p><p><b>Stocks making the biggest moves in the premarket: Altimeter Growth, Johnson &amp; Johnson, FedEx &amp; more:</b></p><p><b>1)&nbsp;Altimeter Growth(AGC) </b>— Southeast Asia's ride-hailing giant Grab isgoing public via a SPAC mergerwith Altimeter Growth, valued at nearly $40 billion. Grab says it intends to list on the Nasdaq under ticker symbol \"GRAB\" following the deal's completion. Altimeter's shares surged nearly 9% in premarket trading.</p><p><b>2)&nbsp;Johnson &amp; Johnson(JNJ) </b>— Shares of the drugmaker fell 2.8% in the premarket after the Food and Drug Administrationsaid it is asking states to pauseadministering J&amp;J's Covid-19 vaccine after six people in the U.S. developed a rare disorder involving blood clots. The FDA said the recommendation is \"out of an abundance of caution.\"Modernashares popped more than 7% in early trading on the news.</p><p><b>3)&nbsp;FedEx(FDX)</b> — Shares of the shipping company rose in premarket trading about KeyBanc Capital Markets upgraded FedEx to \"overweight.\" The Wall Street firm also set a $350 per share price target on FedEx. KeyBanc said FedEx can still grow volume even with the return to in-person shopping.</p><p><b>4)&nbsp;JetBlue(JBLU),Spirit Airlines(SAVE)</b> — Shares of the airlines popped in premarket trading after Susquehanna Financial Group upgraded JetBlue and Spirit Airlines to “positive.” “With a recovery in U.S. domestic air travel underway, we want to own the low-cost carriers,” the firm’s analyst told clients.</p><p><b>5)&nbsp;Booking Holdings(BKNG) </b>— The travel company gained in premarket trading after Jefferies upgraded Booking to “buy” from “hold” on a rebound in global travel. The first also hiked its 12-month price target to $2,800 per share from $2,300 per share.</p><p><b>6)&nbsp;3M(MMM) </b>— Shares of the manufacturing giant edged lower in the premarket after Deutsche Bank added a “catalyst call” sell on 3M. The Wall Street firm said the stock has curiously outperformed in recent weeks despite Deutsche Bank’s expectation for a miss on upcoming earnings.</p><p><b>7)&nbsp;NortonLifeLock(NLOK)</b> — The security company dipped in premarket trading after Bank of America initiated the stock with an “underperform” rating and a $19 per share price target. “Last year’s COVID-related spike in demand may unwind in the next few quarters and the company may return to negative trends in churn and subscriber additions, negatively impacting the revenue growth,” the firm said.</p><p><b>8)&nbsp;Honeywell(HON)</b> — Shares of Honeywell rose in premarket trade after Deutsche Bank put a catalyst call “buy” rating on the stock. The firm said investors are unenthusiastic about Honeywell, despite a recovery taking hold.</p><p><b>9)&nbsp;Bristol-Myers Squibb(BMY) </b>— Shares of the pharmaceutical company rose in the premarket about Truist upgraded Bristol-Myers Squibb to “buy” from “hold” with a $74 per share price target. The Wall Street firm said it likes Bristol-Myers Squibb’s drug pipeline.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-04-13 20:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul><li>Stock futures drop after US officials call for pause of J&amp;J vaccine rollout.&nbsp;</li><li>In&nbsp;addition,&nbsp;markets look to key U.S. inflation data.</li><li>The benchmark 10-year Treasury yield inched closer to 1.7%.</li><li>Bitcoin set new record, trading above $63,000.</li><li>Altimeter Growth, Johnson &amp; Johnson, FedEx &amp; more making the biggest moves in the premarket</li></ul><p>(April 13)&nbsp;Stock futures sank Tuesday morning after U.S. federal health officials called for a pause in the rollout of Johnson &amp; Johnson's (JNJ) COVID-19 vaccine amid concerns over rare blood clots in some individuals who received the inoculation.</p><p>At 8:05 a.m. ET, Dow E-minis were down 110 points, or 0.33%, S&amp;P 500 E-minis were down 10.5 points, or 0.25% and Nasdaq 100 E-minis were down 6.5&nbsp;points, or 0.05%.</p><p><img src=\"https://static.tigerbbs.com/fec9ca3c4d5c22a6aabf5a7bd8286a08\" tg-width=\"1242\" tg-height=\"492\" referrerpolicy=\"no-referrer\"></p><p>The benchmark 10-year Treasury yield inched closer to 1.7% before the Labor Department’s data that is expected to show U.S. consumer prices rose 0.5% in March from 0.4% in February. The report is due at 8:30 a.m. ET (1230 GMT).</p><p>Among stocks, U.S.-listed shares of e-commerce firm JD.com and search giant Baidu fell about 2% each in premarket trading as China’s market regulator warned internet companies to stop using any banned practices.</p><p><img src=\"https://static.tigerbbs.com/57e53e80a4150ceca7c4290b9a0e14ce\" tg-width=\"282\" tg-height=\"80\" referrerpolicy=\"no-referrer\"></p><p>Cryptocurrency and blockchain-related firms including Riot Blockchain and Marathon Digital Holdings jumped 9% and 8% as bitcoin prices soared 4.5%, a day ahead of listing of Coinbase, the largest U.S. cryptocurrency exchange.</p><p><img src=\"https://static.tigerbbs.com/759502388fc3c70949384c724fa01051\" tg-width=\"292\" tg-height=\"355\" referrerpolicy=\"no-referrer\"></p><p><b>Stocks making the biggest moves in the premarket: Altimeter Growth, Johnson &amp; Johnson, FedEx &amp; more:</b></p><p><b>1)&nbsp;Altimeter Growth(AGC) </b>— Southeast Asia's ride-hailing giant Grab isgoing public via a SPAC mergerwith Altimeter Growth, valued at nearly $40 billion. Grab says it intends to list on the Nasdaq under ticker symbol \"GRAB\" following the deal's completion. Altimeter's shares surged nearly 9% in premarket trading.</p><p><b>2)&nbsp;Johnson &amp; Johnson(JNJ) </b>— Shares of the drugmaker fell 2.8% in the premarket after the Food and Drug Administrationsaid it is asking states to pauseadministering J&amp;J's Covid-19 vaccine after six people in the U.S. developed a rare disorder involving blood clots. The FDA said the recommendation is \"out of an abundance of caution.\"Modernashares popped more than 7% in early trading on the news.</p><p><b>3)&nbsp;FedEx(FDX)</b> — Shares of the shipping company rose in premarket trading about KeyBanc Capital Markets upgraded FedEx to \"overweight.\" The Wall Street firm also set a $350 per share price target on FedEx. KeyBanc said FedEx can still grow volume even with the return to in-person shopping.</p><p><b>4)&nbsp;JetBlue(JBLU),Spirit Airlines(SAVE)</b> — Shares of the airlines popped in premarket trading after Susquehanna Financial Group upgraded JetBlue and Spirit Airlines to “positive.” “With a recovery in U.S. domestic air travel underway, we want to own the low-cost carriers,” the firm’s analyst told clients.</p><p><b>5)&nbsp;Booking Holdings(BKNG) </b>— The travel company gained in premarket trading after Jefferies upgraded Booking to “buy” from “hold” on a rebound in global travel. The first also hiked its 12-month price target to $2,800 per share from $2,300 per share.</p><p><b>6)&nbsp;3M(MMM) </b>— Shares of the manufacturing giant edged lower in the premarket after Deutsche Bank added a “catalyst call” sell on 3M. The Wall Street firm said the stock has curiously outperformed in recent weeks despite Deutsche Bank’s expectation for a miss on upcoming earnings.</p><p><b>7)&nbsp;NortonLifeLock(NLOK)</b> — The security company dipped in premarket trading after Bank of America initiated the stock with an “underperform” rating and a $19 per share price target. “Last year’s COVID-related spike in demand may unwind in the next few quarters and the company may return to negative trends in churn and subscriber additions, negatively impacting the revenue growth,” the firm said.</p><p><b>8)&nbsp;Honeywell(HON)</b> — Shares of Honeywell rose in premarket trade after Deutsche Bank put a catalyst call “buy” rating on the stock. The firm said investors are unenthusiastic about Honeywell, despite a recovery taking hold.</p><p><b>9)&nbsp;Bristol-Myers Squibb(BMY) </b>— Shares of the pharmaceutical company rose in the premarket about Truist upgraded Bristol-Myers Squibb to “buy” from “hold” with a $74 per share price target. The Wall Street firm said it likes Bristol-Myers Squibb’s drug pipeline.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1179268763","content_text":"Stock futures drop after US officials call for pause of J&J vaccine rollout. In addition, markets look to key U.S. inflation data.The benchmark 10-year Treasury yield inched closer to 1.7%.Bitcoin set new record, trading above $63,000.Altimeter Growth, Johnson & Johnson, FedEx & more making the biggest moves in the premarket(April 13) Stock futures sank Tuesday morning after U.S. federal health officials called for a pause in the rollout of Johnson & Johnson's (JNJ) COVID-19 vaccine amid concerns over rare blood clots in some individuals who received the inoculation.At 8:05 a.m. ET, Dow E-minis were down 110 points, or 0.33%, S&P 500 E-minis were down 10.5 points, or 0.25% and Nasdaq 100 E-minis were down 6.5 points, or 0.05%.The benchmark 10-year Treasury yield inched closer to 1.7% before the Labor Department’s data that is expected to show U.S. consumer prices rose 0.5% in March from 0.4% in February. The report is due at 8:30 a.m. ET (1230 GMT).Among stocks, U.S.-listed shares of e-commerce firm JD.com and search giant Baidu fell about 2% each in premarket trading as China’s market regulator warned internet companies to stop using any banned practices.Cryptocurrency and blockchain-related firms including Riot Blockchain and Marathon Digital Holdings jumped 9% and 8% as bitcoin prices soared 4.5%, a day ahead of listing of Coinbase, the largest U.S. cryptocurrency exchange.Stocks making the biggest moves in the premarket: Altimeter Growth, Johnson & Johnson, FedEx & more:1) Altimeter Growth(AGC) — Southeast Asia's ride-hailing giant Grab isgoing public via a SPAC mergerwith Altimeter Growth, valued at nearly $40 billion. Grab says it intends to list on the Nasdaq under ticker symbol \"GRAB\" following the deal's completion. Altimeter's shares surged nearly 9% in premarket trading.2) Johnson & Johnson(JNJ) — Shares of the drugmaker fell 2.8% in the premarket after the Food and Drug Administrationsaid it is asking states to pauseadministering J&J's Covid-19 vaccine after six people in the U.S. developed a rare disorder involving blood clots. The FDA said the recommendation is \"out of an abundance of caution.\"Modernashares popped more than 7% in early trading on the news.3) FedEx(FDX) — Shares of the shipping company rose in premarket trading about KeyBanc Capital Markets upgraded FedEx to \"overweight.\" The Wall Street firm also set a $350 per share price target on FedEx. KeyBanc said FedEx can still grow volume even with the return to in-person shopping.4) JetBlue(JBLU),Spirit Airlines(SAVE) — Shares of the airlines popped in premarket trading after Susquehanna Financial Group upgraded JetBlue and Spirit Airlines to “positive.” “With a recovery in U.S. domestic air travel underway, we want to own the low-cost carriers,” the firm’s analyst told clients.5) Booking Holdings(BKNG) — The travel company gained in premarket trading after Jefferies upgraded Booking to “buy” from “hold” on a rebound in global travel. The first also hiked its 12-month price target to $2,800 per share from $2,300 per share.6) 3M(MMM) — Shares of the manufacturing giant edged lower in the premarket after Deutsche Bank added a “catalyst call” sell on 3M. The Wall Street firm said the stock has curiously outperformed in recent weeks despite Deutsche Bank’s expectation for a miss on upcoming earnings.7) NortonLifeLock(NLOK) — The security company dipped in premarket trading after Bank of America initiated the stock with an “underperform” rating and a $19 per share price target. “Last year’s COVID-related spike in demand may unwind in the next few quarters and the company may return to negative trends in churn and subscriber additions, negatively impacting the revenue growth,” the firm said.8) Honeywell(HON) — Shares of Honeywell rose in premarket trade after Deutsche Bank put a catalyst call “buy” rating on the stock. The firm said investors are unenthusiastic about Honeywell, despite a recovery taking hold.9) Bristol-Myers Squibb(BMY) — Shares of the pharmaceutical company rose in the premarket about Truist upgraded Bristol-Myers Squibb to “buy” from “hold” with a $74 per share price target. The Wall Street firm said it likes Bristol-Myers Squibb’s drug pipeline.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":999,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345236635,"gmtCreate":1618316988927,"gmtModify":1634293770169,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Patience&nbsp;","listText":"Patience&nbsp;","text":"Patience","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/345236635","repostId":"1178797310","repostType":4,"repost":{"id":"1178797310","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1618312466,"share":"https://www.laohu8.com/m/news/1178797310?lang=&edition=full","pubTime":"2021-04-13 19:14","market":"us","language":"en","title":"Johnson & Johnson dipped about 3% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1178797310","media":"Tiger Newspress","summary":"U.S. Calls For Pause On Johnson & Johnson Vaccine After Clotting Cases.KEY POINTSThe FDA said it is ","content":"<p>U.S. Calls For Pause On Johnson &amp; Johnson Vaccine After Clotting Cases.</p><p><img src=\"https://static.tigerbbs.com/44ed5a479ba7fa5976bb70090ba50c81\" tg-width=\"1242\" tg-height=\"2148\" referrerpolicy=\"no-referrer\"></p><p><b>KEY POINTS</b></p><ul><li>The FDA said it is asking states to temporarily halt using J&amp;J’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.</li><li>The FDA said the recommendation is “out of an abundance of caution.”</li><li>All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot.</li></ul><p>The Food and Drug Administration said Tuesday it is asking states to temporarily halt usingJohnson &amp; Johnson’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.</p><p>The FDA said the recommendation is “out of an abundance of caution.”</p><p>“Right now, these adverse events appear to be extremely rare,” the FDA said in a joint statement with the Centers for Disease Control and Prevention. “COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously.”</p><p><img src=\"https://static.tigerbbs.com/b4808bfed9dcd9d1cc27ef92e3ba3dcf\" tg-width=\"512\" tg-height=\"232\">A White House spokesman referred CNBC to HHS when asked for comment.</p><p>All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot. Doctors typically treat that type of blood clot with heparin but health regulators noted that could be dangerous in this case and recommended a different treatment.</p><p>J&amp;J said in a statement that “no clear causal relationship” has been identified between the blood clots and the vaccine, adding it is working closely with regulators to assess the data.</p><p>People who receive the vaccine and “develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider,” the FDA and CDC said.</p><p>Shares of J&amp;J were down more than 3% in premarket trading Tuesday.</p><p>The CDC will convene a meeting of the Advisory Committee on Immunization Practices on Wednesday to further review the cases, federal health regulators said Tuesday. The FDA is also investigating the cases.</p><p>J&amp;J’s Covid-19 vaccine, like Pfizer’s and Moderna’s shots, received emergency use authorization from the FDA to start distributing the doses across the U.S. An EUA grants conditional clearance based on two months of safety data, pending full approval which usually requires at least six months of data.</p><p>When J&amp;J submitted its Covid vaccine data to the FDA in February, no specific concerns were identified when analyzed by age, race and comorbidities, according to the agency. The FDA said at the time the most common side effects reported were headache and fatigue, followed by muscle aches, nausea and fever.</p><p>The New York Timesfirst reportedthe news.</p><p>It’s unclear how the pause will impact J&amp;J’s goal to deliver 100 million doses to the U.S. by the end of May. The company has already been plagued by manufacturing issues of its vaccine.</p><p>Last week, Europe’s medicines regulatorsaid it found a possible linkbetween the coronavirus vaccine developed by AstraZeneca and the University of Oxford and rare blood clotting issues. AstraZeneca has not received authorization for use in the U.S.</p><p>Emer Cooke, executive director of the European Medicines Agency, said in a televised news conference last week that unusual blood clotting with low blood platelets would be added as a “very rare” side effect to the vaccine’s product information, along with a slew of other possible adverse reactions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Johnson & Johnson dipped about 3% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJohnson & Johnson dipped about 3% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-04-13 19:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. Calls For Pause On Johnson &amp; Johnson Vaccine After Clotting Cases.</p><p><img src=\"https://static.tigerbbs.com/44ed5a479ba7fa5976bb70090ba50c81\" tg-width=\"1242\" tg-height=\"2148\" referrerpolicy=\"no-referrer\"></p><p><b>KEY POINTS</b></p><ul><li>The FDA said it is asking states to temporarily halt using J&amp;J’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.</li><li>The FDA said the recommendation is “out of an abundance of caution.”</li><li>All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot.</li></ul><p>The Food and Drug Administration said Tuesday it is asking states to temporarily halt usingJohnson &amp; Johnson’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.</p><p>The FDA said the recommendation is “out of an abundance of caution.”</p><p>“Right now, these adverse events appear to be extremely rare,” the FDA said in a joint statement with the Centers for Disease Control and Prevention. “COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously.”</p><p><img src=\"https://static.tigerbbs.com/b4808bfed9dcd9d1cc27ef92e3ba3dcf\" tg-width=\"512\" tg-height=\"232\">A White House spokesman referred CNBC to HHS when asked for comment.</p><p>All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot. Doctors typically treat that type of blood clot with heparin but health regulators noted that could be dangerous in this case and recommended a different treatment.</p><p>J&amp;J said in a statement that “no clear causal relationship” has been identified between the blood clots and the vaccine, adding it is working closely with regulators to assess the data.</p><p>People who receive the vaccine and “develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider,” the FDA and CDC said.</p><p>Shares of J&amp;J were down more than 3% in premarket trading Tuesday.</p><p>The CDC will convene a meeting of the Advisory Committee on Immunization Practices on Wednesday to further review the cases, federal health regulators said Tuesday. The FDA is also investigating the cases.</p><p>J&amp;J’s Covid-19 vaccine, like Pfizer’s and Moderna’s shots, received emergency use authorization from the FDA to start distributing the doses across the U.S. An EUA grants conditional clearance based on two months of safety data, pending full approval which usually requires at least six months of data.</p><p>When J&amp;J submitted its Covid vaccine data to the FDA in February, no specific concerns were identified when analyzed by age, race and comorbidities, according to the agency. The FDA said at the time the most common side effects reported were headache and fatigue, followed by muscle aches, nausea and fever.</p><p>The New York Timesfirst reportedthe news.</p><p>It’s unclear how the pause will impact J&amp;J’s goal to deliver 100 million doses to the U.S. by the end of May. The company has already been plagued by manufacturing issues of its vaccine.</p><p>Last week, Europe’s medicines regulatorsaid it found a possible linkbetween the coronavirus vaccine developed by AstraZeneca and the University of Oxford and rare blood clotting issues. AstraZeneca has not received authorization for use in the U.S.</p><p>Emer Cooke, executive director of the European Medicines Agency, said in a televised news conference last week that unusual blood clotting with low blood platelets would be added as a “very rare” side effect to the vaccine’s product information, along with a slew of other possible adverse reactions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178797310","content_text":"U.S. Calls For Pause On Johnson & Johnson Vaccine After Clotting Cases.KEY POINTSThe FDA said it is asking states to temporarily halt using J&J’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.The FDA said the recommendation is “out of an abundance of caution.”All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot.The Food and Drug Administration said Tuesday it is asking states to temporarily halt usingJohnson & Johnson’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.The FDA said the recommendation is “out of an abundance of caution.”“Right now, these adverse events appear to be extremely rare,” the FDA said in a joint statement with the Centers for Disease Control and Prevention. “COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously.”A White House spokesman referred CNBC to HHS when asked for comment.All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot. Doctors typically treat that type of blood clot with heparin but health regulators noted that could be dangerous in this case and recommended a different treatment.J&J said in a statement that “no clear causal relationship” has been identified between the blood clots and the vaccine, adding it is working closely with regulators to assess the data.People who receive the vaccine and “develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider,” the FDA and CDC said.Shares of J&J were down more than 3% in premarket trading Tuesday.The CDC will convene a meeting of the Advisory Committee on Immunization Practices on Wednesday to further review the cases, federal health regulators said Tuesday. The FDA is also investigating the cases.J&J’s Covid-19 vaccine, like Pfizer’s and Moderna’s shots, received emergency use authorization from the FDA to start distributing the doses across the U.S. An EUA grants conditional clearance based on two months of safety data, pending full approval which usually requires at least six months of data.When J&J submitted its Covid vaccine data to the FDA in February, no specific concerns were identified when analyzed by age, race and comorbidities, according to the agency. The FDA said at the time the most common side effects reported were headache and fatigue, followed by muscle aches, nausea and fever.The New York Timesfirst reportedthe news.It’s unclear how the pause will impact J&J’s goal to deliver 100 million doses to the U.S. by the end of May. The company has already been plagued by manufacturing issues of its vaccine.Last week, Europe’s medicines regulatorsaid it found a possible linkbetween the coronavirus vaccine developed by AstraZeneca and the University of Oxford and rare blood clotting issues. AstraZeneca has not received authorization for use in the U.S.Emer Cooke, executive director of the European Medicines Agency, said in a televised news conference last week that unusual blood clotting with low blood platelets would be added as a “very rare” side effect to the vaccine’s product information, along with a slew of other possible adverse reactions.","news_type":1,"symbols_score_info":{"JNJ":0.9}},"isVote":1,"tweetType":1,"viewCount":1390,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":342045142,"gmtCreate":1618138483986,"gmtModify":1634294731867,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/342045142","repostId":"2126035617","repostType":2,"isVote":1,"tweetType":1,"viewCount":1443,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":342045957,"gmtCreate":1618138456579,"gmtModify":1634294732109,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/342045957","repostId":"2126032195","repostType":2,"isVote":1,"tweetType":1,"viewCount":839,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346242989,"gmtCreate":1618057149041,"gmtModify":1634295040280,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Ok, not bad","listText":"Ok, not bad","text":"Ok, not bad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346242989","repostId":"1142324412","repostType":4,"isVote":1,"tweetType":1,"viewCount":1250,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346246541,"gmtCreate":1618057093683,"gmtModify":1634295040524,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Why not","listText":"Why not","text":"Why not","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/346246541","repostId":"2126333180","repostType":4,"isVote":1,"tweetType":1,"viewCount":270,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346159612,"gmtCreate":1618016548036,"gmtModify":1634295239328,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Okay...&nbsp;","listText":"Okay...&nbsp;","text":"Okay...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/346159612","repostId":"1168300924","repostType":4,"repost":{"id":"1168300924","kind":"news","pubTimestamp":1617955250,"share":"https://www.laohu8.com/m/news/1168300924?lang=&edition=full","pubTime":"2021-04-09 16:00","market":"us","language":"en","title":"Next Week’s IPO Lineup Is Growing. It Could Be Busy.","url":"https://stock-news.laohu8.com/highlight/detail?id=1168300924","media":"barrons","summary":"The second week of April is shaping up to be a relatively strong time for the IPO market. As many as four more companies are making their stock-market debuts, bringing the total to at least six.Coinbase, the largest U.S. cryptocurrency exchange,is slated to open for trading on Wednesday, April 14. Applovin and TuSimple are listing the next day, three people familiar with the situation said. Agilon Health ismaking its debut that Thursday.And Alkami Technology,a bank software company, and Karat Pa","content":"<p>The second week of April is shaping up to be a relatively strong time for the IPO market. As many as four more companies are making their stock-market debuts, bringing the total to at least six.</p><p>Coinbase, the largest U.S. cryptocurrency exchange,is slated to open for trading on Wednesday, April 14. Applovin and TuSimple are listing the next day, three people familiar with the situation said. Agilon Health ismaking its debut that Thursday.</p><p>And Alkami Technology,a bank software company, and Karat Packaging, whichmakes environmentally-friendly disposable food service products, are also reportedly going public.</p><p>This week, by way of contrast, two companies, Reneo Pharmaceuticals and VectivBio Holding, are listing. Both are small biotech companies that areslated to begin trading on the Nasdaq on Friday.</p><p>Applovin on Wednesday set terms for its initial public offering. It is offering 25 million shares at $75 to $85 each, which means it could raise as much as $2.13 billion if the stock sells at the high end of that range. The company plans to trade on the Nasdaq under the symbol APP.</p><p>Eighteen underwriters are listed in the Applovin prospectus, includingMorgan Stanley(ticker: MS),JPMorgan Chase(JPM),KKR,&nbsp;Bank of America‘s (BAC) BofA Securities, andCitigroup(C).</p><p>Founded in 2012, Applovin&nbsp;provides software&nbsp;used by mobile-game developers to grow their businesses.&nbsp; Some 410 million people a day open apps that contain Applovin software, according to the company. Applovin also has a portfolio of more than 200 free-to-play mobile games with 32 million daily users.</p><p>In 2018, KKRbought a minority stakein Applovin for $400 million, valuing Applovin at $2 billion at the time. Applovin in February acquired Adjust, a firm that helps mobile-app developers measure the performance of apps and prevent fraud, for $1 billion. KKR will own 67.4% of the company after the IPO, theprospectus said.</p><p>With 357,955,309 shares outstanding, Applovin’s market capitalization could hit $30 billion.</p><p>TuSimple also set terms for its IPO. The self-driving technology company could raise as much as $1.3 billion; it is offering nearly 34 million shares at $35 to $39 each. It will trade on the Nasdaq under the ticker TSP.</p><p>Morgan Stanley(MS),Citigroup,and J.P. Morgan (JPM) are lead bookrunners on the deal.</p><p>Founded in 2015, TuSimple is looking to transform the $800 billion trucking industry. The San Diego company, which has plants in Tucson, Shanghai, and Beijing, in addition to operations in Japan, is developing an autonomous freight network for long-haul, semi-trucks that it says will increase efficiency and safety on the road, while cutting operating costs.</p><p>TuSimple develops software for the Level 4 self-driving, long-haul trucks, which can see up to 1,000 meters away, equivalent to 30 seconds of driving time. High-definition maps provide accuracy within five centimeters.</p><p>The company is partnering withNavistar(NAV) to develop trucks for the North American market by 2024,its prospectus said. TuSimple has another partnership withVolkswagensubsidiary TRATON for trucks in Europe. Navistar, TRATON, and United Parcel Service (UPS) are all investors.</p><p>TuSimple has raised $800 million in funding, including a $350 million round in November led by VectoIQ.BlackRock(BR), Fidelity Management &amp; Research Co and Capital Group are in talks to buy up to 10.1 million TuSimple shares at the IPO price, the prospectus said.</p><p>The company will have 212,263,328 shares outstanding, meaning TuSimple’s market cap could climb to $8.3 billion. TuSimple, however, is not profitable. Losses widened to $177.9 million in 2020 from $84.9 million in 2019. Revenue jumped nearly 160% to $1.8 million in 2020.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Next Week’s IPO Lineup Is Growing. It Could Be Busy.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNext Week’s IPO Lineup Is Growing. It Could Be Busy.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 16:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/next-weeks-ipo-lineup-is-growing-it-could-be-busy-51617907448?mod=hp_LEAD_1_B_2><strong>barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The second week of April is shaping up to be a relatively strong time for the IPO market. As many as four more companies are making their stock-market debuts, bringing the total to at least six....</p>\n\n<a href=\"https://www.barrons.com/articles/next-weeks-ipo-lineup-is-growing-it-could-be-busy-51617907448?mod=hp_LEAD_1_B_2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.barrons.com/articles/next-weeks-ipo-lineup-is-growing-it-could-be-busy-51617907448?mod=hp_LEAD_1_B_2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168300924","content_text":"The second week of April is shaping up to be a relatively strong time for the IPO market. As many as four more companies are making their stock-market debuts, bringing the total to at least six.Coinbase, the largest U.S. cryptocurrency exchange,is slated to open for trading on Wednesday, April 14. Applovin and TuSimple are listing the next day, three people familiar with the situation said. Agilon Health ismaking its debut that Thursday.And Alkami Technology,a bank software company, and Karat Packaging, whichmakes environmentally-friendly disposable food service products, are also reportedly going public.This week, by way of contrast, two companies, Reneo Pharmaceuticals and VectivBio Holding, are listing. Both are small biotech companies that areslated to begin trading on the Nasdaq on Friday.Applovin on Wednesday set terms for its initial public offering. It is offering 25 million shares at $75 to $85 each, which means it could raise as much as $2.13 billion if the stock sells at the high end of that range. The company plans to trade on the Nasdaq under the symbol APP.Eighteen underwriters are listed in the Applovin prospectus, includingMorgan Stanley(ticker: MS),JPMorgan Chase(JPM),KKR, Bank of America‘s (BAC) BofA Securities, andCitigroup(C).Founded in 2012, Applovin provides software used by mobile-game developers to grow their businesses.  Some 410 million people a day open apps that contain Applovin software, according to the company. Applovin also has a portfolio of more than 200 free-to-play mobile games with 32 million daily users.In 2018, KKRbought a minority stakein Applovin for $400 million, valuing Applovin at $2 billion at the time. Applovin in February acquired Adjust, a firm that helps mobile-app developers measure the performance of apps and prevent fraud, for $1 billion. KKR will own 67.4% of the company after the IPO, theprospectus said.With 357,955,309 shares outstanding, Applovin’s market capitalization could hit $30 billion.TuSimple also set terms for its IPO. The self-driving technology company could raise as much as $1.3 billion; it is offering nearly 34 million shares at $35 to $39 each. It will trade on the Nasdaq under the ticker TSP.Morgan Stanley(MS),Citigroup,and J.P. Morgan (JPM) are lead bookrunners on the deal.Founded in 2015, TuSimple is looking to transform the $800 billion trucking industry. The San Diego company, which has plants in Tucson, Shanghai, and Beijing, in addition to operations in Japan, is developing an autonomous freight network for long-haul, semi-trucks that it says will increase efficiency and safety on the road, while cutting operating costs.TuSimple develops software for the Level 4 self-driving, long-haul trucks, which can see up to 1,000 meters away, equivalent to 30 seconds of driving time. High-definition maps provide accuracy within five centimeters.The company is partnering withNavistar(NAV) to develop trucks for the North American market by 2024,its prospectus said. TuSimple has another partnership withVolkswagensubsidiary TRATON for trucks in Europe. Navistar, TRATON, and United Parcel Service (UPS) are all investors.TuSimple has raised $800 million in funding, including a $350 million round in November led by VectoIQ.BlackRock(BR), Fidelity Management & Research Co and Capital Group are in talks to buy up to 10.1 million TuSimple shares at the IPO price, the prospectus said.The company will have 212,263,328 shares outstanding, meaning TuSimple’s market cap could climb to $8.3 billion. TuSimple, however, is not profitable. Losses widened to $177.9 million in 2020 from $84.9 million in 2019. Revenue jumped nearly 160% to $1.8 million in 2020.","news_type":1,"symbols_score_info":{"ALKT":0.9,"APP":0.9,"COIN":0.9,"KRT":0.9,"RPHM":0.9,"TSP":0.9,"VECT":0.9}},"isVote":1,"tweetType":1,"viewCount":652,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346150591,"gmtCreate":1618016499113,"gmtModify":1634295240053,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Well.....","listText":"Well.....","text":"Well.....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346150591","repostId":"1149004993","repostType":4,"repost":{"id":"1149004993","kind":"news","pubTimestamp":1617975407,"share":"https://www.laohu8.com/m/news/1149004993?lang=&edition=full","pubTime":"2021-04-09 21:36","market":"us","language":"en","title":"Google urges U.S. to work with the EU on trade as enforcers abroad pursue regulations","url":"https://stock-news.laohu8.com/highlight/detail?id=1149004993","media":"CNBC","summary":"KEY POINTS\n\nGoogle urged the Biden administration to join a technology and trade council with the Eu","content":"<div>\n<p>KEY POINTS\n\nGoogle urged the Biden administration to join a technology and trade council with the European Union as enforcers abroad pursue more robust regulation of the industry.\nKaran Bhatia, Google...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/09/google-urges-us-to-work-with-the-eu-on-trade.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Google urges U.S. to work with the EU on trade as enforcers abroad pursue regulations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoogle urges U.S. to work with the EU on trade as enforcers abroad pursue regulations\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 21:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/04/09/google-urges-us-to-work-with-the-eu-on-trade.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nGoogle urged the Biden administration to join a technology and trade council with the European Union as enforcers abroad pursue more robust regulation of the industry.\nKaran Bhatia, Google...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/09/google-urges-us-to-work-with-the-eu-on-trade.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.cnbc.com/2021/04/09/google-urges-us-to-work-with-the-eu-on-trade.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1149004993","content_text":"KEY POINTS\n\nGoogle urged the Biden administration to join a technology and trade council with the European Union as enforcers abroad pursue more robust regulation of the industry.\nKaran Bhatia, Google’s vice president of government affairs and policy, warned in a blog post Friday that the technology trade relationship between the two governments “is fraying.”\nHe urged the Biden administration to join an EU-U.S. Trade and Technology Council proposed by the European Commission and to expand it.\n\nGoogle urged the Biden administration to join a technology and trade council with the European Union as enforcers abroad pursue more robust regulation of the industry.\nKaran Bhatia,Google’s vice president of government affairs and policy, warned in a blog post Friday that the technology trade relationship between the two governments “is fraying.” Bhatia said the U.S. policy “has been largely reduced to pressing Europe to follow U.S. supply chain initiatives” while Europe pursues broad regulations, like taxes on digital services.\nBhatia said such trends hurt both economies and will make it harder for them to address new global challenges or “partner with emerging economies in Asia.”\nGoogle’s appeal to the Biden administration comes as the president has begun staffing his team with well-known critics of the tech industry, including his Federal Trade Commission nominee Lina Khan and National Economic Council advisor Tim Wu. The company faces antitrust lawsuits from several states and the Department of Justice, which began under the previous administration.\nStill, Google’s appeal to the Biden administration may indicate that it sees it as a potential ally for fending off the most impactful legislation from the EU and preventing a splintered version of the internet across continents. The European Commission has shown a greater willingness over the past several years to crack down on the U.S.-based tech companies, waging several competition penalties against Google before the U.S. ever brought an antitrust case against it. Still, the U.S. has recently ramped up enforcement and Biden’s recent appointments indicate a continuation of that policy.\nIn the blog post, Bhatia urged the Biden administration to join an EU-U.S. Trade and Technology Council proposed by the European Commission and to expand it. In order to be most effective, both countries should consult with one another before taking significant actions that could impact the way the other engages in tech trade negotiations, he said. Bhatia added that this would mean the EU should consult the council about whether regulations like its sweeping Digital Markets Act would “reflect the EU-U.S. values-based alliance.”\nThat legislation would authorize major penalties for companies including Google for failing to comply with certain standards to prevent self-preferencing of their own products and services in their markets. Violations could be punished with hefty fines or even divestment of parts of the business.\nThe blog was published ahead of Bhatia’s appearance at an event hosted by the Center for Strategic and International Studieson Friday.","news_type":1,"symbols_score_info":{"GOOG":0.9,"GOOGL":0.9}},"isVote":1,"tweetType":1,"viewCount":719,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346150386,"gmtCreate":1618016472245,"gmtModify":1634295240401,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Ah.....","listText":"Ah.....","text":"Ah.....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346150386","repostId":"1180128899","repostType":4,"isVote":1,"tweetType":1,"viewCount":560,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346150043,"gmtCreate":1618016439482,"gmtModify":1634295240521,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Good good","listText":"Good good","text":"Good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346150043","repostId":"2126315033","repostType":4,"isVote":1,"tweetType":1,"viewCount":458,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346030053,"gmtCreate":1617972186472,"gmtModify":1634295452749,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"My fav","listText":"My fav","text":"My fav","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346030053","repostId":"1181428561","repostType":4,"repost":{"id":"1181428561","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1617962530,"share":"https://www.laohu8.com/m/news/1181428561?lang=&edition=full","pubTime":"2021-04-09 18:02","market":"us","language":"en","title":"In Tesla's Quest For $25,000 EV, Panasonic Thinks It Has Crucial Role To Play","url":"https://stock-news.laohu8.com/highlight/detail?id=1181428561","media":"Benzinga","summary":"What Happened: While Tesla plans to make the new 4680 cells in-house, it has alsoasked Panasonicto begin producing them.Last September, Tesla announced thedesign of the tabless 4680battery cell, which increases power by six times and energy by five times. The design supposedly boosts the range by 16%.The new 4680 cells, named after their dimensions of 46-millimeter diameter and 80-millimeter height, are larger than the cells currently supplied by Panasonic to Tesla.However, Yasuaki Takamoto, Pan","content":"<p><b>Tesla Inc.’s</b>&nbsp;TSLA&nbsp;oldest battery supplier&nbsp;<b>Panasonic Corp.</b>&nbsp;PCRFY&nbsp;believes its ability to produce a next-generation battery will play a crucial role in the electric vehicle maker’splanto launch a $25,000 electric vehicle, BloombergreportedThursday.</p><p><b>What Happened:</b>&nbsp;While Tesla plans to make the new 4680 cells in-house, it has alsoasked Panasonicto begin producing them.</p><p>Last September, Tesla announced thedesign of the tabless 4680battery cell, which increases power by six times and energy by five times. The design supposedly boosts the range by 16%.</p><p>The new 4680 cells, named after their dimensions of 46-millimeter diameter and 80-millimeter height, are larger than the cells currently supplied by Panasonic to Tesla.</p><p>While the larger capacity of the new cells will enable Tesla to reduce the number of battery cells and result in fewer parts for its electric vehicles, it also makes the cells more difficult to produce, according to Bloomberg. In addition, the cells are prone to overheating and susceptible to particle contamination, which are frequent causes of EV battery fires.</p><p>However, Yasuaki Takamoto, Panasonic’s EV battery head, told Bloomberg that the company’s ability to produce 2.5 billion cells a year without major safety issues and Panasonic’s production expansion only at a pace at which it can maintain safety standards gives it an advantage in producing the new cells. Panasonic is reportedly working to set up a prototype production line to make the cells.</p><p><b>Why It Matters:</b>&nbsp;Production of the new battery is crucial for Tesla and will enable it to accelerate the manufacture of new vehicles like the Tesla Semi truck and the Plaid Plus S, in addition to the new planned $25,000 electric car. Tesla CEO Elon Musk said in March thatbattery cell constraintshave impacted the Tesla Semi rollout.</p><p>For Panasonic, the production of the new battery is expected to generate more revenues as the company seeks to reduce dependence on its core, low-margin consumer electronic business. Tesla’s electric vehicles have enabled Panasonic’s battery business to rake in profits.</p><p>It wasreportedin March that South Korean battery supplier<b>LG Energy Solutions</b>– a unit of LG Chem, is in talks to make Tesla’s new battery in the U.S. and Europe.</p><p><b>Price Action:</b>&nbsp;Panasonic OTC shares closed 2.1% lower on Thursday at $12.57. Tesla shares closed 1.9% higher at $683.80 and further rose almost 0.5% in the after-hours session.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>In Tesla's Quest For $25,000 EV, Panasonic Thinks It Has Crucial Role To Play</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIn Tesla's Quest For $25,000 EV, Panasonic Thinks It Has Crucial Role To Play\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-04-09 18:02</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Tesla Inc.’s</b>&nbsp;TSLA&nbsp;oldest battery supplier&nbsp;<b>Panasonic Corp.</b>&nbsp;PCRFY&nbsp;believes its ability to produce a next-generation battery will play a crucial role in the electric vehicle maker’splanto launch a $25,000 electric vehicle, BloombergreportedThursday.</p><p><b>What Happened:</b>&nbsp;While Tesla plans to make the new 4680 cells in-house, it has alsoasked Panasonicto begin producing them.</p><p>Last September, Tesla announced thedesign of the tabless 4680battery cell, which increases power by six times and energy by five times. The design supposedly boosts the range by 16%.</p><p>The new 4680 cells, named after their dimensions of 46-millimeter diameter and 80-millimeter height, are larger than the cells currently supplied by Panasonic to Tesla.</p><p>While the larger capacity of the new cells will enable Tesla to reduce the number of battery cells and result in fewer parts for its electric vehicles, it also makes the cells more difficult to produce, according to Bloomberg. In addition, the cells are prone to overheating and susceptible to particle contamination, which are frequent causes of EV battery fires.</p><p>However, Yasuaki Takamoto, Panasonic’s EV battery head, told Bloomberg that the company’s ability to produce 2.5 billion cells a year without major safety issues and Panasonic’s production expansion only at a pace at which it can maintain safety standards gives it an advantage in producing the new cells. Panasonic is reportedly working to set up a prototype production line to make the cells.</p><p><b>Why It Matters:</b>&nbsp;Production of the new battery is crucial for Tesla and will enable it to accelerate the manufacture of new vehicles like the Tesla Semi truck and the Plaid Plus S, in addition to the new planned $25,000 electric car. Tesla CEO Elon Musk said in March thatbattery cell constraintshave impacted the Tesla Semi rollout.</p><p>For Panasonic, the production of the new battery is expected to generate more revenues as the company seeks to reduce dependence on its core, low-margin consumer electronic business. Tesla’s electric vehicles have enabled Panasonic’s battery business to rake in profits.</p><p>It wasreportedin March that South Korean battery supplier<b>LG Energy Solutions</b>– a unit of LG Chem, is in talks to make Tesla’s new battery in the U.S. and Europe.</p><p><b>Price Action:</b>&nbsp;Panasonic OTC shares closed 2.1% lower on Thursday at $12.57. Tesla shares closed 1.9% higher at $683.80 and further rose almost 0.5% in the after-hours session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181428561","content_text":"Tesla Inc.’s TSLA oldest battery supplier Panasonic Corp. PCRFY believes its ability to produce a next-generation battery will play a crucial role in the electric vehicle maker’splanto launch a $25,000 electric vehicle, BloombergreportedThursday.What Happened: While Tesla plans to make the new 4680 cells in-house, it has alsoasked Panasonicto begin producing them.Last September, Tesla announced thedesign of the tabless 4680battery cell, which increases power by six times and energy by five times. The design supposedly boosts the range by 16%.The new 4680 cells, named after their dimensions of 46-millimeter diameter and 80-millimeter height, are larger than the cells currently supplied by Panasonic to Tesla.While the larger capacity of the new cells will enable Tesla to reduce the number of battery cells and result in fewer parts for its electric vehicles, it also makes the cells more difficult to produce, according to Bloomberg. In addition, the cells are prone to overheating and susceptible to particle contamination, which are frequent causes of EV battery fires.However, Yasuaki Takamoto, Panasonic’s EV battery head, told Bloomberg that the company’s ability to produce 2.5 billion cells a year without major safety issues and Panasonic’s production expansion only at a pace at which it can maintain safety standards gives it an advantage in producing the new cells. Panasonic is reportedly working to set up a prototype production line to make the cells.Why It Matters: Production of the new battery is crucial for Tesla and will enable it to accelerate the manufacture of new vehicles like the Tesla Semi truck and the Plaid Plus S, in addition to the new planned $25,000 electric car. Tesla CEO Elon Musk said in March thatbattery cell constraintshave impacted the Tesla Semi rollout.For Panasonic, the production of the new battery is expected to generate more revenues as the company seeks to reduce dependence on its core, low-margin consumer electronic business. Tesla’s electric vehicles have enabled Panasonic’s battery business to rake in profits.It wasreportedin March that South Korean battery supplierLG Energy Solutions– a unit of LG Chem, is in talks to make Tesla’s new battery in the U.S. and Europe.Price Action: Panasonic OTC shares closed 2.1% lower on Thursday at $12.57. Tesla shares closed 1.9% higher at $683.80 and further rose almost 0.5% in the after-hours session.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":593,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346097862,"gmtCreate":1617972164356,"gmtModify":1634295453230,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Aduh, come on","listText":"Aduh, come on","text":"Aduh, come on","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346097862","repostId":"2126842820","repostType":4,"isVote":1,"tweetType":1,"viewCount":378,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346097955,"gmtCreate":1617972121677,"gmtModify":1634295453471,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Ya, careful","listText":"Ya, careful","text":"Ya, careful","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346097955","repostId":"2126084008","repostType":4,"isVote":1,"tweetType":1,"viewCount":395,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346094682,"gmtCreate":1617972066846,"gmtModify":1634295453710,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Lower, I want to enter","listText":"Lower, I want to enter","text":"Lower, I want to enter","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346094682","isVote":1,"tweetType":1,"viewCount":571,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346095563,"gmtCreate":1617971993752,"gmtModify":1634295454317,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"No confidence&nbsp;","listText":"No confidence&nbsp;","text":"No confidence","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346095563","repostId":"1184496379","repostType":4,"isVote":1,"tweetType":1,"viewCount":397,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":805698753,"gmtCreate":1627873984672,"gmtModify":1633755712277,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Buy buy buy, up up up","listText":"Buy buy buy, up up up","text":"Buy buy buy, up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/805698753","repostId":"1170689665","repostType":4,"repost":{"id":"1170689665","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627857540,"share":"https://www.laohu8.com/m/news/1170689665?lang=&edition=full","pubTime":"2021-08-02 06:39","market":"us","language":"en","title":"Alibaba,Uber, DraftKings, GM, Roku, EA, ViacomCBS, and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1170689665","media":"Tiger Newspress","summary":"The parade of second-quarter results continues this week. No fewer than 143 S&P 500 companies are on deck to report, in addition to hundreds of small caps. Ferrari, Vornado Realty Trust, Take-Two Interactive Software, and Simon Property Group will get the ball rolling on Monday. Then Lyft, Alibaba Group Holding, Nikola, Under Armour, Eli Lilly, and ConocoPhillips release their results on Tuesday.Wednesday will be particularly busy:General Motors,Uber Technologies,Etsy,Electronic Arts,Western Dig","content":"<p>The parade of second-quarter results continues this week. No fewer than 143 S&amp;P 500 companies are on deck to report, in addition to hundreds of small caps. Ferrari, Vornado Realty Trust, Take-Two Interactive Software, and Simon Property Group will get the ball rolling on Monday. Then Lyft, Alibaba Group Holding, Nikola, Under Armour, Eli Lilly, and ConocoPhillips release their results on Tuesday.</p>\n<p>Wednesday will be particularly busy:General Motors,Uber Technologies,Etsy,Electronic Arts,Western Digital,Roku,CVS Health,Kraft Heinz, and SoftBank all report.Beyond Meat,Yelp,Wayfair, Moderna, and&nbsp;ViacomCBS&nbsp;go on Thursday and&nbsp;DraftKings,Canopy Growth,and Tripadvisor will close the week on Friday.Chinese Education Corporation&nbsp;New Oriental Education &amp; Technology Group Inc. and&nbsp;TAL Education Group&nbsp;cancels scheduled earnings release and earnings call.</p>\n<p><img src=\"https://static.tigerbbs.com/94057bf11ca8d7311db6c075ba98727b\" tg-width=\"1706\" tg-height=\"740\" referrerpolicy=\"no-referrer\"></p>\n<p>The highlight on the&nbsp;economic&nbsp;calendar this week will be Jobs Friday. The Bureau of Labor Statistics is expected to show a gain of 625,000 nonfarm payrolls in July, following June’s 850,000. The unemployment rate is seen holding just below 6%.</p>\n<p>Other data out this week include the Institute for Supply Management’s Manufacturing Purchasing Managers’ Index for July on Monday, followed by the Services equivalent on Wednesday. Both measures of economic activity are forecast to come in at around 61, which would signify strong expansion.</p>\n<p><b>Monday 8/2</b></p>\n<p>CNA Financial,Global Payments,JELD-WEN Holding,Loews,Arista Networks,Leggett &amp; Platt,Vornado Realty Trust, ZoomInfo Technologies, Woodward, Take-Two Interactive Software, Heineken, Trex, Ferrari,Ultra Clean Holdings,and Simon Property Group are expected to release financial results.</p>\n<p>GE stock&nbsp;will open for trading Monday at about $104 a share, after closing Friday at $12.95. The company completed its 1-for-8 reverse stock split Friday evening.</p>\n<p><b>The Institute for Supply</b>&nbsp;Management releases its Manufacturing Purchasing Managers’ Index for July. Consensus estimate is for a 60.8 reading, up from 60.6 in June.</p>\n<p><b>The Census Bureau</b>&nbsp;reports construction spending for June. Expectations are for a 0.4% month-over-month rise, after a 0.3% decline in May.</p>\n<p><b>Tuesday 8/3</b></p>\n<p>Eaton, BP, Under Armour, Lyft,Clorox,Amgen,Akamai Technologies,Cummins, Eli Lilly, Alibaba Group Holding, Nikola, EnPro Industries,Warner Music Group,Pitney Bowes,Tennant,Phillips 66,KKR,Gartner,Henry Schein,Dun &amp; Bradstreet Holdings,ConocoPhillips, and&nbsp;Jacobs Engineering Grouphost conference calls to discuss financial results.</p>\n<p><b>The Census Bureau</b>&nbsp;is slated to report factory orders for June. Economists predict that orders increased 1.0% during the month, compared with a 1.7% rise in May.</p>\n<p><b>Wednesday 8/4</b></p>\n<p>Sony Group,CVS Health, Kraft Heinz, SoftBank, General Motors, Progressive, Etsy, Electronic Arts, Western Digital, Uber Technologies, Roku,MGM Resorts International,Fox, and Re/Max Holdings are expected to host earnings calls.</p>\n<p><b>The Bureau of Economic</b>&nbsp;Analysis reports light-vehicle sales for July. Expectations call for a seasonally adjusted annual rate of 15.3 million vehicles, versus 15.4 million in June.</p>\n<p><b>The ISM releases</b>&nbsp;its Services PMI for July. Consensus estimate is for a 60.8 reading, compared with June’s 60.1.</p>\n<p><b>ADP releases</b>&nbsp;its National Employment report for July. Consensus estimate is for a 635,000 gain in nonfarm private-sector employment, following an increase of 692,000 in June.</p>\n<p><b>Thursday 8/5</b></p>\n<p>Zillow Group,Beyond Meat, Yelp, Wayfair, Kellogg,Bayer,HanesBrands, Moderna,Regeneron Pharmaceuticals,Switch,Cushman &amp; Wakefield,ViacomCBS,Cigna,Duke Energy,Square,News Corp,and&nbsp;Siemensare expected to report financial results.</p>\n<p>Friday 8/6</p>\n<p><b>The BLS releases the jobs report</b>&nbsp;for July. Economists forecast a 800,000 rise in nonfarm payrolls, after an 850,000 gain in June. The unemployment rate is expected to edge down to 5.8% from 5.9%.</p>\n<p>DraftKings,Dominion Energy,Gannett,MGM Growth Properties,AMC Networks,Canopy Growth, Tripadvisor,Spectrum Brands Holdings,E.W. Scripps,Cinemark Holdings, and Manitowoc host conference calls to discuss financial results.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba,Uber, DraftKings, GM, Roku, EA, ViacomCBS, and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba,Uber, DraftKings, GM, Roku, EA, ViacomCBS, and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-02 06:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The parade of second-quarter results continues this week. No fewer than 143 S&amp;P 500 companies are on deck to report, in addition to hundreds of small caps. Ferrari, Vornado Realty Trust, Take-Two Interactive Software, and Simon Property Group will get the ball rolling on Monday. Then Lyft, Alibaba Group Holding, Nikola, Under Armour, Eli Lilly, and ConocoPhillips release their results on Tuesday.</p>\n<p>Wednesday will be particularly busy:General Motors,Uber Technologies,Etsy,Electronic Arts,Western Digital,Roku,CVS Health,Kraft Heinz, and SoftBank all report.Beyond Meat,Yelp,Wayfair, Moderna, and&nbsp;ViacomCBS&nbsp;go on Thursday and&nbsp;DraftKings,Canopy Growth,and Tripadvisor will close the week on Friday.Chinese Education Corporation&nbsp;New Oriental Education &amp; Technology Group Inc. and&nbsp;TAL Education Group&nbsp;cancels scheduled earnings release and earnings call.</p>\n<p><img src=\"https://static.tigerbbs.com/94057bf11ca8d7311db6c075ba98727b\" tg-width=\"1706\" tg-height=\"740\" referrerpolicy=\"no-referrer\"></p>\n<p>The highlight on the&nbsp;economic&nbsp;calendar this week will be Jobs Friday. The Bureau of Labor Statistics is expected to show a gain of 625,000 nonfarm payrolls in July, following June’s 850,000. The unemployment rate is seen holding just below 6%.</p>\n<p>Other data out this week include the Institute for Supply Management’s Manufacturing Purchasing Managers’ Index for July on Monday, followed by the Services equivalent on Wednesday. Both measures of economic activity are forecast to come in at around 61, which would signify strong expansion.</p>\n<p><b>Monday 8/2</b></p>\n<p>CNA Financial,Global Payments,JELD-WEN Holding,Loews,Arista Networks,Leggett &amp; Platt,Vornado Realty Trust, ZoomInfo Technologies, Woodward, Take-Two Interactive Software, Heineken, Trex, Ferrari,Ultra Clean Holdings,and Simon Property Group are expected to release financial results.</p>\n<p>GE stock&nbsp;will open for trading Monday at about $104 a share, after closing Friday at $12.95. The company completed its 1-for-8 reverse stock split Friday evening.</p>\n<p><b>The Institute for Supply</b>&nbsp;Management releases its Manufacturing Purchasing Managers’ Index for July. Consensus estimate is for a 60.8 reading, up from 60.6 in June.</p>\n<p><b>The Census Bureau</b>&nbsp;reports construction spending for June. Expectations are for a 0.4% month-over-month rise, after a 0.3% decline in May.</p>\n<p><b>Tuesday 8/3</b></p>\n<p>Eaton, BP, Under Armour, Lyft,Clorox,Amgen,Akamai Technologies,Cummins, Eli Lilly, Alibaba Group Holding, Nikola, EnPro Industries,Warner Music Group,Pitney Bowes,Tennant,Phillips 66,KKR,Gartner,Henry Schein,Dun &amp; Bradstreet Holdings,ConocoPhillips, and&nbsp;Jacobs Engineering Grouphost conference calls to discuss financial results.</p>\n<p><b>The Census Bureau</b>&nbsp;is slated to report factory orders for June. Economists predict that orders increased 1.0% during the month, compared with a 1.7% rise in May.</p>\n<p><b>Wednesday 8/4</b></p>\n<p>Sony Group,CVS Health, Kraft Heinz, SoftBank, General Motors, Progressive, Etsy, Electronic Arts, Western Digital, Uber Technologies, Roku,MGM Resorts International,Fox, and Re/Max Holdings are expected to host earnings calls.</p>\n<p><b>The Bureau of Economic</b>&nbsp;Analysis reports light-vehicle sales for July. Expectations call for a seasonally adjusted annual rate of 15.3 million vehicles, versus 15.4 million in June.</p>\n<p><b>The ISM releases</b>&nbsp;its Services PMI for July. Consensus estimate is for a 60.8 reading, compared with June’s 60.1.</p>\n<p><b>ADP releases</b>&nbsp;its National Employment report for July. Consensus estimate is for a 635,000 gain in nonfarm private-sector employment, following an increase of 692,000 in June.</p>\n<p><b>Thursday 8/5</b></p>\n<p>Zillow Group,Beyond Meat, Yelp, Wayfair, Kellogg,Bayer,HanesBrands, Moderna,Regeneron Pharmaceuticals,Switch,Cushman &amp; Wakefield,ViacomCBS,Cigna,Duke Energy,Square,News Corp,and&nbsp;Siemensare expected to report financial results.</p>\n<p>Friday 8/6</p>\n<p><b>The BLS releases the jobs report</b>&nbsp;for July. Economists forecast a 800,000 rise in nonfarm payrolls, after an 850,000 gain in June. The unemployment rate is expected to edge down to 5.8% from 5.9%.</p>\n<p>DraftKings,Dominion Energy,Gannett,MGM Growth Properties,AMC Networks,Canopy Growth, Tripadvisor,Spectrum Brands Holdings,E.W. Scripps,Cinemark Holdings, and Manitowoc host conference calls to discuss financial results.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170689665","content_text":"The parade of second-quarter results continues this week. No fewer than 143 S&P 500 companies are on deck to report, in addition to hundreds of small caps. Ferrari, Vornado Realty Trust, Take-Two Interactive Software, and Simon Property Group will get the ball rolling on Monday. Then Lyft, Alibaba Group Holding, Nikola, Under Armour, Eli Lilly, and ConocoPhillips release their results on Tuesday.\nWednesday will be particularly busy:General Motors,Uber Technologies,Etsy,Electronic Arts,Western Digital,Roku,CVS Health,Kraft Heinz, and SoftBank all report.Beyond Meat,Yelp,Wayfair, Moderna, and ViacomCBS go on Thursday and DraftKings,Canopy Growth,and Tripadvisor will close the week on Friday.Chinese Education Corporation New Oriental Education & Technology Group Inc. and TAL Education Group cancels scheduled earnings release and earnings call.\n\nThe highlight on the economic calendar this week will be Jobs Friday. The Bureau of Labor Statistics is expected to show a gain of 625,000 nonfarm payrolls in July, following June’s 850,000. The unemployment rate is seen holding just below 6%.\nOther data out this week include the Institute for Supply Management’s Manufacturing Purchasing Managers’ Index for July on Monday, followed by the Services equivalent on Wednesday. Both measures of economic activity are forecast to come in at around 61, which would signify strong expansion.\nMonday 8/2\nCNA Financial,Global Payments,JELD-WEN Holding,Loews,Arista Networks,Leggett & Platt,Vornado Realty Trust, ZoomInfo Technologies, Woodward, Take-Two Interactive Software, Heineken, Trex, Ferrari,Ultra Clean Holdings,and Simon Property Group are expected to release financial results.\nGE stock will open for trading Monday at about $104 a share, after closing Friday at $12.95. The company completed its 1-for-8 reverse stock split Friday evening.\nThe Institute for Supply Management releases its Manufacturing Purchasing Managers’ Index for July. Consensus estimate is for a 60.8 reading, up from 60.6 in June.\nThe Census Bureau reports construction spending for June. Expectations are for a 0.4% month-over-month rise, after a 0.3% decline in May.\nTuesday 8/3\nEaton, BP, Under Armour, Lyft,Clorox,Amgen,Akamai Technologies,Cummins, Eli Lilly, Alibaba Group Holding, Nikola, EnPro Industries,Warner Music Group,Pitney Bowes,Tennant,Phillips 66,KKR,Gartner,Henry Schein,Dun & Bradstreet Holdings,ConocoPhillips, and Jacobs Engineering Grouphost conference calls to discuss financial results.\nThe Census Bureau is slated to report factory orders for June. Economists predict that orders increased 1.0% during the month, compared with a 1.7% rise in May.\nWednesday 8/4\nSony Group,CVS Health, Kraft Heinz, SoftBank, General Motors, Progressive, Etsy, Electronic Arts, Western Digital, Uber Technologies, Roku,MGM Resorts International,Fox, and Re/Max Holdings are expected to host earnings calls.\nThe Bureau of Economic Analysis reports light-vehicle sales for July. Expectations call for a seasonally adjusted annual rate of 15.3 million vehicles, versus 15.4 million in June.\nThe ISM releases its Services PMI for July. Consensus estimate is for a 60.8 reading, compared with June’s 60.1.\nADP releases its National Employment report for July. Consensus estimate is for a 635,000 gain in nonfarm private-sector employment, following an increase of 692,000 in June.\nThursday 8/5\nZillow Group,Beyond Meat, Yelp, Wayfair, Kellogg,Bayer,HanesBrands, Moderna,Regeneron Pharmaceuticals,Switch,Cushman & Wakefield,ViacomCBS,Cigna,Duke Energy,Square,News Corp,and Siemensare expected to report financial results.\nFriday 8/6\nThe BLS releases the jobs report for July. Economists forecast a 800,000 rise in nonfarm payrolls, after an 850,000 gain in June. The unemployment rate is expected to edge down to 5.8% from 5.9%.\nDraftKings,Dominion Energy,Gannett,MGM Growth Properties,AMC Networks,Canopy Growth, Tripadvisor,Spectrum Brands Holdings,E.W. Scripps,Cinemark Holdings, and Manitowoc host conference calls to discuss financial results.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"BABA":0.9,"DKNG":0.9,"EA":0.9,"GE":0.9,"GM":0.9,"ROKU":0.9,"UBER":0.9,"VIAC":0.9}},"isVote":1,"tweetType":1,"viewCount":1466,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":343587055,"gmtCreate":1617725302677,"gmtModify":1631885601727,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Fly high soon!","listText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Fly high soon!","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$Fly high soon!","images":[{"img":"https://static.tigerbbs.com/c56cbd95b9ce97a9d4cb2572740c8d21","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/343587055","isVote":1,"tweetType":1,"viewCount":524,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":346246541,"gmtCreate":1618057093683,"gmtModify":1634295040524,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Why not","listText":"Why not","text":"Why not","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/346246541","repostId":"2126333180","repostType":4,"isVote":1,"tweetType":1,"viewCount":270,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345232604,"gmtCreate":1618317051208,"gmtModify":1634293769627,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Hmm..&nbsp;","listText":"Hmm..&nbsp;","text":"Hmm..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/345232604","repostId":"1179268763","repostType":4,"repost":{"id":"1179268763","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1618315607,"share":"https://www.laohu8.com/m/news/1179268763?lang=&edition=full","pubTime":"2021-04-13 20:06","market":"us","language":"en","title":"Toplines Before US Market Open on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1179268763","media":"Tiger Newspress","summary":"Stock futures drop after US officials call for pause of J&J vaccine rollout. In addition, markets lo","content":"<ul><li>Stock futures drop after US officials call for pause of J&amp;J vaccine rollout.&nbsp;</li><li>In&nbsp;addition,&nbsp;markets look to key U.S. inflation data.</li><li>The benchmark 10-year Treasury yield inched closer to 1.7%.</li><li>Bitcoin set new record, trading above $63,000.</li><li>Altimeter Growth, Johnson &amp; Johnson, FedEx &amp; more making the biggest moves in the premarket</li></ul><p>(April 13)&nbsp;Stock futures sank Tuesday morning after U.S. federal health officials called for a pause in the rollout of Johnson &amp; Johnson's (JNJ) COVID-19 vaccine amid concerns over rare blood clots in some individuals who received the inoculation.</p><p>At 8:05 a.m. ET, Dow E-minis were down 110 points, or 0.33%, S&amp;P 500 E-minis were down 10.5 points, or 0.25% and Nasdaq 100 E-minis were down 6.5&nbsp;points, or 0.05%.</p><p><img src=\"https://static.tigerbbs.com/fec9ca3c4d5c22a6aabf5a7bd8286a08\" tg-width=\"1242\" tg-height=\"492\" referrerpolicy=\"no-referrer\"></p><p>The benchmark 10-year Treasury yield inched closer to 1.7% before the Labor Department’s data that is expected to show U.S. consumer prices rose 0.5% in March from 0.4% in February. The report is due at 8:30 a.m. ET (1230 GMT).</p><p>Among stocks, U.S.-listed shares of e-commerce firm JD.com and search giant Baidu fell about 2% each in premarket trading as China’s market regulator warned internet companies to stop using any banned practices.</p><p><img src=\"https://static.tigerbbs.com/57e53e80a4150ceca7c4290b9a0e14ce\" tg-width=\"282\" tg-height=\"80\" referrerpolicy=\"no-referrer\"></p><p>Cryptocurrency and blockchain-related firms including Riot Blockchain and Marathon Digital Holdings jumped 9% and 8% as bitcoin prices soared 4.5%, a day ahead of listing of Coinbase, the largest U.S. cryptocurrency exchange.</p><p><img src=\"https://static.tigerbbs.com/759502388fc3c70949384c724fa01051\" tg-width=\"292\" tg-height=\"355\" referrerpolicy=\"no-referrer\"></p><p><b>Stocks making the biggest moves in the premarket: Altimeter Growth, Johnson &amp; Johnson, FedEx &amp; more:</b></p><p><b>1)&nbsp;Altimeter Growth(AGC) </b>— Southeast Asia's ride-hailing giant Grab isgoing public via a SPAC mergerwith Altimeter Growth, valued at nearly $40 billion. Grab says it intends to list on the Nasdaq under ticker symbol \"GRAB\" following the deal's completion. Altimeter's shares surged nearly 9% in premarket trading.</p><p><b>2)&nbsp;Johnson &amp; Johnson(JNJ) </b>— Shares of the drugmaker fell 2.8% in the premarket after the Food and Drug Administrationsaid it is asking states to pauseadministering J&amp;J's Covid-19 vaccine after six people in the U.S. developed a rare disorder involving blood clots. The FDA said the recommendation is \"out of an abundance of caution.\"Modernashares popped more than 7% in early trading on the news.</p><p><b>3)&nbsp;FedEx(FDX)</b> — Shares of the shipping company rose in premarket trading about KeyBanc Capital Markets upgraded FedEx to \"overweight.\" The Wall Street firm also set a $350 per share price target on FedEx. KeyBanc said FedEx can still grow volume even with the return to in-person shopping.</p><p><b>4)&nbsp;JetBlue(JBLU),Spirit Airlines(SAVE)</b> — Shares of the airlines popped in premarket trading after Susquehanna Financial Group upgraded JetBlue and Spirit Airlines to “positive.” “With a recovery in U.S. domestic air travel underway, we want to own the low-cost carriers,” the firm’s analyst told clients.</p><p><b>5)&nbsp;Booking Holdings(BKNG) </b>— The travel company gained in premarket trading after Jefferies upgraded Booking to “buy” from “hold” on a rebound in global travel. The first also hiked its 12-month price target to $2,800 per share from $2,300 per share.</p><p><b>6)&nbsp;3M(MMM) </b>— Shares of the manufacturing giant edged lower in the premarket after Deutsche Bank added a “catalyst call” sell on 3M. The Wall Street firm said the stock has curiously outperformed in recent weeks despite Deutsche Bank’s expectation for a miss on upcoming earnings.</p><p><b>7)&nbsp;NortonLifeLock(NLOK)</b> — The security company dipped in premarket trading after Bank of America initiated the stock with an “underperform” rating and a $19 per share price target. “Last year’s COVID-related spike in demand may unwind in the next few quarters and the company may return to negative trends in churn and subscriber additions, negatively impacting the revenue growth,” the firm said.</p><p><b>8)&nbsp;Honeywell(HON)</b> — Shares of Honeywell rose in premarket trade after Deutsche Bank put a catalyst call “buy” rating on the stock. The firm said investors are unenthusiastic about Honeywell, despite a recovery taking hold.</p><p><b>9)&nbsp;Bristol-Myers Squibb(BMY) </b>— Shares of the pharmaceutical company rose in the premarket about Truist upgraded Bristol-Myers Squibb to “buy” from “hold” with a $74 per share price target. The Wall Street firm said it likes Bristol-Myers Squibb’s drug pipeline.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-04-13 20:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul><li>Stock futures drop after US officials call for pause of J&amp;J vaccine rollout.&nbsp;</li><li>In&nbsp;addition,&nbsp;markets look to key U.S. inflation data.</li><li>The benchmark 10-year Treasury yield inched closer to 1.7%.</li><li>Bitcoin set new record, trading above $63,000.</li><li>Altimeter Growth, Johnson &amp; Johnson, FedEx &amp; more making the biggest moves in the premarket</li></ul><p>(April 13)&nbsp;Stock futures sank Tuesday morning after U.S. federal health officials called for a pause in the rollout of Johnson &amp; Johnson's (JNJ) COVID-19 vaccine amid concerns over rare blood clots in some individuals who received the inoculation.</p><p>At 8:05 a.m. ET, Dow E-minis were down 110 points, or 0.33%, S&amp;P 500 E-minis were down 10.5 points, or 0.25% and Nasdaq 100 E-minis were down 6.5&nbsp;points, or 0.05%.</p><p><img src=\"https://static.tigerbbs.com/fec9ca3c4d5c22a6aabf5a7bd8286a08\" tg-width=\"1242\" tg-height=\"492\" referrerpolicy=\"no-referrer\"></p><p>The benchmark 10-year Treasury yield inched closer to 1.7% before the Labor Department’s data that is expected to show U.S. consumer prices rose 0.5% in March from 0.4% in February. The report is due at 8:30 a.m. ET (1230 GMT).</p><p>Among stocks, U.S.-listed shares of e-commerce firm JD.com and search giant Baidu fell about 2% each in premarket trading as China’s market regulator warned internet companies to stop using any banned practices.</p><p><img src=\"https://static.tigerbbs.com/57e53e80a4150ceca7c4290b9a0e14ce\" tg-width=\"282\" tg-height=\"80\" referrerpolicy=\"no-referrer\"></p><p>Cryptocurrency and blockchain-related firms including Riot Blockchain and Marathon Digital Holdings jumped 9% and 8% as bitcoin prices soared 4.5%, a day ahead of listing of Coinbase, the largest U.S. cryptocurrency exchange.</p><p><img src=\"https://static.tigerbbs.com/759502388fc3c70949384c724fa01051\" tg-width=\"292\" tg-height=\"355\" referrerpolicy=\"no-referrer\"></p><p><b>Stocks making the biggest moves in the premarket: Altimeter Growth, Johnson &amp; Johnson, FedEx &amp; more:</b></p><p><b>1)&nbsp;Altimeter Growth(AGC) </b>— Southeast Asia's ride-hailing giant Grab isgoing public via a SPAC mergerwith Altimeter Growth, valued at nearly $40 billion. Grab says it intends to list on the Nasdaq under ticker symbol \"GRAB\" following the deal's completion. Altimeter's shares surged nearly 9% in premarket trading.</p><p><b>2)&nbsp;Johnson &amp; Johnson(JNJ) </b>— Shares of the drugmaker fell 2.8% in the premarket after the Food and Drug Administrationsaid it is asking states to pauseadministering J&amp;J's Covid-19 vaccine after six people in the U.S. developed a rare disorder involving blood clots. The FDA said the recommendation is \"out of an abundance of caution.\"Modernashares popped more than 7% in early trading on the news.</p><p><b>3)&nbsp;FedEx(FDX)</b> — Shares of the shipping company rose in premarket trading about KeyBanc Capital Markets upgraded FedEx to \"overweight.\" The Wall Street firm also set a $350 per share price target on FedEx. KeyBanc said FedEx can still grow volume even with the return to in-person shopping.</p><p><b>4)&nbsp;JetBlue(JBLU),Spirit Airlines(SAVE)</b> — Shares of the airlines popped in premarket trading after Susquehanna Financial Group upgraded JetBlue and Spirit Airlines to “positive.” “With a recovery in U.S. domestic air travel underway, we want to own the low-cost carriers,” the firm’s analyst told clients.</p><p><b>5)&nbsp;Booking Holdings(BKNG) </b>— The travel company gained in premarket trading after Jefferies upgraded Booking to “buy” from “hold” on a rebound in global travel. The first also hiked its 12-month price target to $2,800 per share from $2,300 per share.</p><p><b>6)&nbsp;3M(MMM) </b>— Shares of the manufacturing giant edged lower in the premarket after Deutsche Bank added a “catalyst call” sell on 3M. The Wall Street firm said the stock has curiously outperformed in recent weeks despite Deutsche Bank’s expectation for a miss on upcoming earnings.</p><p><b>7)&nbsp;NortonLifeLock(NLOK)</b> — The security company dipped in premarket trading after Bank of America initiated the stock with an “underperform” rating and a $19 per share price target. “Last year’s COVID-related spike in demand may unwind in the next few quarters and the company may return to negative trends in churn and subscriber additions, negatively impacting the revenue growth,” the firm said.</p><p><b>8)&nbsp;Honeywell(HON)</b> — Shares of Honeywell rose in premarket trade after Deutsche Bank put a catalyst call “buy” rating on the stock. The firm said investors are unenthusiastic about Honeywell, despite a recovery taking hold.</p><p><b>9)&nbsp;Bristol-Myers Squibb(BMY) </b>— Shares of the pharmaceutical company rose in the premarket about Truist upgraded Bristol-Myers Squibb to “buy” from “hold” with a $74 per share price target. The Wall Street firm said it likes Bristol-Myers Squibb’s drug pipeline.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1179268763","content_text":"Stock futures drop after US officials call for pause of J&J vaccine rollout. In addition, markets look to key U.S. inflation data.The benchmark 10-year Treasury yield inched closer to 1.7%.Bitcoin set new record, trading above $63,000.Altimeter Growth, Johnson & Johnson, FedEx & more making the biggest moves in the premarket(April 13) Stock futures sank Tuesday morning after U.S. federal health officials called for a pause in the rollout of Johnson & Johnson's (JNJ) COVID-19 vaccine amid concerns over rare blood clots in some individuals who received the inoculation.At 8:05 a.m. ET, Dow E-minis were down 110 points, or 0.33%, S&P 500 E-minis were down 10.5 points, or 0.25% and Nasdaq 100 E-minis were down 6.5 points, or 0.05%.The benchmark 10-year Treasury yield inched closer to 1.7% before the Labor Department’s data that is expected to show U.S. consumer prices rose 0.5% in March from 0.4% in February. The report is due at 8:30 a.m. ET (1230 GMT).Among stocks, U.S.-listed shares of e-commerce firm JD.com and search giant Baidu fell about 2% each in premarket trading as China’s market regulator warned internet companies to stop using any banned practices.Cryptocurrency and blockchain-related firms including Riot Blockchain and Marathon Digital Holdings jumped 9% and 8% as bitcoin prices soared 4.5%, a day ahead of listing of Coinbase, the largest U.S. cryptocurrency exchange.Stocks making the biggest moves in the premarket: Altimeter Growth, Johnson & Johnson, FedEx & more:1) Altimeter Growth(AGC) — Southeast Asia's ride-hailing giant Grab isgoing public via a SPAC mergerwith Altimeter Growth, valued at nearly $40 billion. Grab says it intends to list on the Nasdaq under ticker symbol \"GRAB\" following the deal's completion. Altimeter's shares surged nearly 9% in premarket trading.2) Johnson & Johnson(JNJ) — Shares of the drugmaker fell 2.8% in the premarket after the Food and Drug Administrationsaid it is asking states to pauseadministering J&J's Covid-19 vaccine after six people in the U.S. developed a rare disorder involving blood clots. The FDA said the recommendation is \"out of an abundance of caution.\"Modernashares popped more than 7% in early trading on the news.3) FedEx(FDX) — Shares of the shipping company rose in premarket trading about KeyBanc Capital Markets upgraded FedEx to \"overweight.\" The Wall Street firm also set a $350 per share price target on FedEx. KeyBanc said FedEx can still grow volume even with the return to in-person shopping.4) JetBlue(JBLU),Spirit Airlines(SAVE) — Shares of the airlines popped in premarket trading after Susquehanna Financial Group upgraded JetBlue and Spirit Airlines to “positive.” “With a recovery in U.S. domestic air travel underway, we want to own the low-cost carriers,” the firm’s analyst told clients.5) Booking Holdings(BKNG) — The travel company gained in premarket trading after Jefferies upgraded Booking to “buy” from “hold” on a rebound in global travel. The first also hiked its 12-month price target to $2,800 per share from $2,300 per share.6) 3M(MMM) — Shares of the manufacturing giant edged lower in the premarket after Deutsche Bank added a “catalyst call” sell on 3M. The Wall Street firm said the stock has curiously outperformed in recent weeks despite Deutsche Bank’s expectation for a miss on upcoming earnings.7) NortonLifeLock(NLOK) — The security company dipped in premarket trading after Bank of America initiated the stock with an “underperform” rating and a $19 per share price target. “Last year’s COVID-related spike in demand may unwind in the next few quarters and the company may return to negative trends in churn and subscriber additions, negatively impacting the revenue growth,” the firm said.8) Honeywell(HON) — Shares of Honeywell rose in premarket trade after Deutsche Bank put a catalyst call “buy” rating on the stock. The firm said investors are unenthusiastic about Honeywell, despite a recovery taking hold.9) Bristol-Myers Squibb(BMY) — Shares of the pharmaceutical company rose in the premarket about Truist upgraded Bristol-Myers Squibb to “buy” from “hold” with a $74 per share price target. The Wall Street firm said it likes Bristol-Myers Squibb’s drug pipeline.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":999,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346095893,"gmtCreate":1617971943012,"gmtModify":1634295454556,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Gold lor","listText":"Gold lor","text":"Gold lor","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/346095893","repostId":"1127800559","repostType":4,"repost":{"id":"1127800559","kind":"news","pubTimestamp":1617970907,"share":"https://www.laohu8.com/m/news/1127800559?lang=&edition=full","pubTime":"2021-04-09 20:21","market":"fut","language":"en","title":"Bitcoin vs. Gold: Which Should You Invest in Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=1127800559","media":"TheStreet","summary":"The performance of bitcoin and gold has diverged dramatically of late, but that doesn’t mean bitcoin","content":"<p>The performance of bitcoin and gold has diverged dramatically of late, but that doesn’t mean bitcoin is going to replace gold.</p>\n<p>Many have wondered whether gold has lost its shine. Certainly over the past 20 years, that’s not the case, but more recently the performance of gold has been lackluster. For 2021, gold is down about 9%, while other asset classes such as equities, real estate and even the dollar have risen higher. The latter, often moving counter to gold and other metals, is up about 3% for 2021.</p>\n<p>So what is bringing gold down? Extreme government monetary stimulus was supposed to bring “wild” inflation to the U.S. and the rest of the world. The heavy liquidity has been a boon for the stock market, with the S&amp;P 500 rising nearly 90% since the depths of late March 2020. Inflation is starting to simmer, though, and that would normally be a signal to goldbugs everywhere to start buying the metal. But curiously, that hasn’t occurred yet.</p>\n<p>Bitcoin, on the other hand, is up in 2021 an astonishing 99%! This coming off a remarkable 302% gain in 2020. Pandemic or not, investors and traders were more than interested watchers of bitcoin. The&nbsp;outperformance&nbsp;vs. gold and other asset classes is stunning, and many pundits are predicting enormous price rises by bitcoin into the future. Just two years ago, we heard of some “wild” predictions of bitcoin reaching “$100K within a couple of years.” Those people were laughed and mocked at then, but with bitcoin now selling around $58,000, it’s not that crazy anymore to consider that target a likelihood.</p>\n<p>But what about gold? Have governments passed on diversifying with the yellow metal permanently in favor of other asset classes such as currencies? Are the old models of inflation and currency de-basing no longer relevant? Or is bitcoin soon to become the new store of exchange, replacing fiat currencies altogether, as more investors abandon the dollar, euro, yen and yuan? These are all important questions to ask as we continue to see more adaptation to this mysterious cryptocurrency.</p>\n<p>I, for one, do not believe that bitcoin will replace gold. Bitcoin will have relevance and have a place for trade and exchange as more banks and firms come around to it. But in the end, gold is still going to be the metal of choice for most investors, as has been the case throughout history.</p>\n<p>If inflation does somehow get out of control, bitcoin won’t be the asset that major investors will turn to, that’s for certain. Bitcoin offers little to no protection against inflation, and it is not tied or correlated to any currency. In the short run, gold may be under-appreciated. But we don’t have to wait for the metal to start heating up. Having some gold, and even some bitcoin, for diversification purposes is a smart way to go.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bitcoin vs. Gold: Which Should You Invest in Now?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBitcoin vs. Gold: Which Should You Invest in Now?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 20:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/bitcoin-versus-gold-which-should-you-invest-in-now><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The performance of bitcoin and gold has diverged dramatically of late, but that doesn’t mean bitcoin is going to replace gold.\nMany have wondered whether gold has lost its shine. Certainly over the ...</p>\n\n<a href=\"https://www.thestreet.com/investing/bitcoin-versus-gold-which-should-you-invest-in-now\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GBTC":"Grayscale Bitcoin Trust ETF"},"source_url":"https://www.thestreet.com/investing/bitcoin-versus-gold-which-should-you-invest-in-now","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127800559","content_text":"The performance of bitcoin and gold has diverged dramatically of late, but that doesn’t mean bitcoin is going to replace gold.\nMany have wondered whether gold has lost its shine. Certainly over the past 20 years, that’s not the case, but more recently the performance of gold has been lackluster. For 2021, gold is down about 9%, while other asset classes such as equities, real estate and even the dollar have risen higher. The latter, often moving counter to gold and other metals, is up about 3% for 2021.\nSo what is bringing gold down? Extreme government monetary stimulus was supposed to bring “wild” inflation to the U.S. and the rest of the world. The heavy liquidity has been a boon for the stock market, with the S&P 500 rising nearly 90% since the depths of late March 2020. Inflation is starting to simmer, though, and that would normally be a signal to goldbugs everywhere to start buying the metal. But curiously, that hasn’t occurred yet.\nBitcoin, on the other hand, is up in 2021 an astonishing 99%! This coming off a remarkable 302% gain in 2020. Pandemic or not, investors and traders were more than interested watchers of bitcoin. The outperformance vs. gold and other asset classes is stunning, and many pundits are predicting enormous price rises by bitcoin into the future. Just two years ago, we heard of some “wild” predictions of bitcoin reaching “$100K within a couple of years.” Those people were laughed and mocked at then, but with bitcoin now selling around $58,000, it’s not that crazy anymore to consider that target a likelihood.\nBut what about gold? Have governments passed on diversifying with the yellow metal permanently in favor of other asset classes such as currencies? Are the old models of inflation and currency de-basing no longer relevant? Or is bitcoin soon to become the new store of exchange, replacing fiat currencies altogether, as more investors abandon the dollar, euro, yen and yuan? These are all important questions to ask as we continue to see more adaptation to this mysterious cryptocurrency.\nI, for one, do not believe that bitcoin will replace gold. Bitcoin will have relevance and have a place for trade and exchange as more banks and firms come around to it. But in the end, gold is still going to be the metal of choice for most investors, as has been the case throughout history.\nIf inflation does somehow get out of control, bitcoin won’t be the asset that major investors will turn to, that’s for certain. Bitcoin offers little to no protection against inflation, and it is not tied or correlated to any currency. In the short run, gold may be under-appreciated. But we don’t have to wait for the metal to start heating up. Having some gold, and even some bitcoin, for diversification purposes is a smart way to go.","news_type":1,"symbols_score_info":{"BTCmain":0.9,"GCmain":0.9,"GOLDmain":0.9,"XBTmain":0.9,"GBTC":0.9}},"isVote":1,"tweetType":1,"viewCount":130,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":341797111,"gmtCreate":1617853897533,"gmtModify":1634296132726,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"airline still the best","listText":"airline still the best","text":"airline still the best","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/341797111","repostId":"1143591118","repostType":4,"repost":{"id":"1143591118","kind":"news","pubTimestamp":1617853594,"share":"https://www.laohu8.com/m/news/1143591118?lang=&edition=full","pubTime":"2021-04-08 11:46","market":"sg","language":"en","title":"Singapore now accounts for a third of the world’s cruises, its tourism body says","url":"https://stock-news.laohu8.com/highlight/detail?id=1143591118","media":"cnbc","summary":"KEY POINTS\n\nSingapore currently accounts for a third of the world’s cruises, its tourism body said o","content":"<div>\n<p>KEY POINTS\n\nSingapore currently accounts for a third of the world’s cruises, its tourism body said on Wednesday, owing to the roaring success of its “cruises to nowhere” at a time of crisis in the ...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/08/singapore-accounts-for-a-third-of-worlds-cruises-tourism-board-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore now accounts for a third of the world’s cruises, its tourism body says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore now accounts for a third of the world’s cruises, its tourism body says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-08 11:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/04/08/singapore-accounts-for-a-third-of-worlds-cruises-tourism-board-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nSingapore currently accounts for a third of the world’s cruises, its tourism body said on Wednesday, owing to the roaring success of its “cruises to nowhere” at a time of crisis in the ...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/08/singapore-accounts-for-a-third-of-worlds-cruises-tourism-board-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.cnbc.com/2021/04/08/singapore-accounts-for-a-third-of-worlds-cruises-tourism-board-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1143591118","content_text":"KEY POINTS\n\nSingapore currently accounts for a third of the world’s cruises, its tourism body said on Wednesday, owing to the roaring success of its “cruises to nowhere” at a time of crisis in the industry globally.\nCruises have yet to restart in many parts of the world after taking a beating from the coronavirus pandemic, with some of the earliest big outbreaks found on cruise ships.\nSingapore has seen relatively few domestic Covid-19 cases since last year.\n\nSingapore currently accounts for a third of the world’s cruises its tourism body said on Wednesday, owing to the roaring success of its “cruises to nowhere” at a time of crisis in the industry globally.\nCruises have yet to restart in many parts of the world after taking a beating from the coronavirus pandemic, with some of the earliest big outbreaks found on cruise ships.\nSingapore has seen relatively few domestic Covid-19 cases since last year.\nThe Singapore cruises are open only to its 5.7 million residents, who have been unable to leave the tiny country for leisure and have settled instead for activities like staycations and even indoor camping.\nThe cruises recorded about 120,000 passengers, according to the Singapore Tourism Board, and run at lower capacity, with stringent health protocols.\nSTB did not cite a source for its industry data.\nSome cruises from the Caribbean are expected to resume from June while the U.S. Centers for Disease has retained tight curbs on resuming cruises from the United States.\nSome cruises have operated in parts of Europe, Asia and the South Pacific, according to the Cruise Lines International Association.\nRoyal Caribbean said this month that it was extending the season in Singapore for its Quantum of the Seas ship due to “overwhelming demand” through October.\nGenting Cruise Lines and Royal Caribbean launched their pilot cruises late last year.\nSTB Chief Executive Keith Tan said Singapore did not expect to be leading in cruises for long.\n“Over the next few months, I certainly believe there will be more resumption of cruise business in the Caribbean, and in the Mediterranean as well,” Tan said.\nSingapore’s tourism industry has been hit hard by the pandemic, with visitors dropping nearly 86% to 2.7 million last year.","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":342,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346242989,"gmtCreate":1618057149041,"gmtModify":1634295040280,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Ok, not bad","listText":"Ok, not bad","text":"Ok, not bad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346242989","repostId":"1142324412","repostType":4,"isVote":1,"tweetType":1,"viewCount":1250,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346159612,"gmtCreate":1618016548036,"gmtModify":1634295239328,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Okay...&nbsp;","listText":"Okay...&nbsp;","text":"Okay...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/346159612","repostId":"1168300924","repostType":4,"repost":{"id":"1168300924","kind":"news","pubTimestamp":1617955250,"share":"https://www.laohu8.com/m/news/1168300924?lang=&edition=full","pubTime":"2021-04-09 16:00","market":"us","language":"en","title":"Next Week’s IPO Lineup Is Growing. It Could Be Busy.","url":"https://stock-news.laohu8.com/highlight/detail?id=1168300924","media":"barrons","summary":"The second week of April is shaping up to be a relatively strong time for the IPO market. As many as four more companies are making their stock-market debuts, bringing the total to at least six.Coinbase, the largest U.S. cryptocurrency exchange,is slated to open for trading on Wednesday, April 14. Applovin and TuSimple are listing the next day, three people familiar with the situation said. Agilon Health ismaking its debut that Thursday.And Alkami Technology,a bank software company, and Karat Pa","content":"<p>The second week of April is shaping up to be a relatively strong time for the IPO market. As many as four more companies are making their stock-market debuts, bringing the total to at least six.</p><p>Coinbase, the largest U.S. cryptocurrency exchange,is slated to open for trading on Wednesday, April 14. Applovin and TuSimple are listing the next day, three people familiar with the situation said. Agilon Health ismaking its debut that Thursday.</p><p>And Alkami Technology,a bank software company, and Karat Packaging, whichmakes environmentally-friendly disposable food service products, are also reportedly going public.</p><p>This week, by way of contrast, two companies, Reneo Pharmaceuticals and VectivBio Holding, are listing. Both are small biotech companies that areslated to begin trading on the Nasdaq on Friday.</p><p>Applovin on Wednesday set terms for its initial public offering. It is offering 25 million shares at $75 to $85 each, which means it could raise as much as $2.13 billion if the stock sells at the high end of that range. The company plans to trade on the Nasdaq under the symbol APP.</p><p>Eighteen underwriters are listed in the Applovin prospectus, includingMorgan Stanley(ticker: MS),JPMorgan Chase(JPM),KKR,&nbsp;Bank of America‘s (BAC) BofA Securities, andCitigroup(C).</p><p>Founded in 2012, Applovin&nbsp;provides software&nbsp;used by mobile-game developers to grow their businesses.&nbsp; Some 410 million people a day open apps that contain Applovin software, according to the company. Applovin also has a portfolio of more than 200 free-to-play mobile games with 32 million daily users.</p><p>In 2018, KKRbought a minority stakein Applovin for $400 million, valuing Applovin at $2 billion at the time. Applovin in February acquired Adjust, a firm that helps mobile-app developers measure the performance of apps and prevent fraud, for $1 billion. KKR will own 67.4% of the company after the IPO, theprospectus said.</p><p>With 357,955,309 shares outstanding, Applovin’s market capitalization could hit $30 billion.</p><p>TuSimple also set terms for its IPO. The self-driving technology company could raise as much as $1.3 billion; it is offering nearly 34 million shares at $35 to $39 each. It will trade on the Nasdaq under the ticker TSP.</p><p>Morgan Stanley(MS),Citigroup,and J.P. Morgan (JPM) are lead bookrunners on the deal.</p><p>Founded in 2015, TuSimple is looking to transform the $800 billion trucking industry. The San Diego company, which has plants in Tucson, Shanghai, and Beijing, in addition to operations in Japan, is developing an autonomous freight network for long-haul, semi-trucks that it says will increase efficiency and safety on the road, while cutting operating costs.</p><p>TuSimple develops software for the Level 4 self-driving, long-haul trucks, which can see up to 1,000 meters away, equivalent to 30 seconds of driving time. High-definition maps provide accuracy within five centimeters.</p><p>The company is partnering withNavistar(NAV) to develop trucks for the North American market by 2024,its prospectus said. TuSimple has another partnership withVolkswagensubsidiary TRATON for trucks in Europe. Navistar, TRATON, and United Parcel Service (UPS) are all investors.</p><p>TuSimple has raised $800 million in funding, including a $350 million round in November led by VectoIQ.BlackRock(BR), Fidelity Management &amp; Research Co and Capital Group are in talks to buy up to 10.1 million TuSimple shares at the IPO price, the prospectus said.</p><p>The company will have 212,263,328 shares outstanding, meaning TuSimple’s market cap could climb to $8.3 billion. TuSimple, however, is not profitable. Losses widened to $177.9 million in 2020 from $84.9 million in 2019. Revenue jumped nearly 160% to $1.8 million in 2020.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Next Week’s IPO Lineup Is Growing. It Could Be Busy.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNext Week’s IPO Lineup Is Growing. It Could Be Busy.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 16:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/next-weeks-ipo-lineup-is-growing-it-could-be-busy-51617907448?mod=hp_LEAD_1_B_2><strong>barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The second week of April is shaping up to be a relatively strong time for the IPO market. As many as four more companies are making their stock-market debuts, bringing the total to at least six....</p>\n\n<a href=\"https://www.barrons.com/articles/next-weeks-ipo-lineup-is-growing-it-could-be-busy-51617907448?mod=hp_LEAD_1_B_2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.barrons.com/articles/next-weeks-ipo-lineup-is-growing-it-could-be-busy-51617907448?mod=hp_LEAD_1_B_2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168300924","content_text":"The second week of April is shaping up to be a relatively strong time for the IPO market. As many as four more companies are making their stock-market debuts, bringing the total to at least six.Coinbase, the largest U.S. cryptocurrency exchange,is slated to open for trading on Wednesday, April 14. Applovin and TuSimple are listing the next day, three people familiar with the situation said. Agilon Health ismaking its debut that Thursday.And Alkami Technology,a bank software company, and Karat Packaging, whichmakes environmentally-friendly disposable food service products, are also reportedly going public.This week, by way of contrast, two companies, Reneo Pharmaceuticals and VectivBio Holding, are listing. Both are small biotech companies that areslated to begin trading on the Nasdaq on Friday.Applovin on Wednesday set terms for its initial public offering. It is offering 25 million shares at $75 to $85 each, which means it could raise as much as $2.13 billion if the stock sells at the high end of that range. The company plans to trade on the Nasdaq under the symbol APP.Eighteen underwriters are listed in the Applovin prospectus, includingMorgan Stanley(ticker: MS),JPMorgan Chase(JPM),KKR, Bank of America‘s (BAC) BofA Securities, andCitigroup(C).Founded in 2012, Applovin provides software used by mobile-game developers to grow their businesses.  Some 410 million people a day open apps that contain Applovin software, according to the company. Applovin also has a portfolio of more than 200 free-to-play mobile games with 32 million daily users.In 2018, KKRbought a minority stakein Applovin for $400 million, valuing Applovin at $2 billion at the time. Applovin in February acquired Adjust, a firm that helps mobile-app developers measure the performance of apps and prevent fraud, for $1 billion. KKR will own 67.4% of the company after the IPO, theprospectus said.With 357,955,309 shares outstanding, Applovin’s market capitalization could hit $30 billion.TuSimple also set terms for its IPO. The self-driving technology company could raise as much as $1.3 billion; it is offering nearly 34 million shares at $35 to $39 each. It will trade on the Nasdaq under the ticker TSP.Morgan Stanley(MS),Citigroup,and J.P. Morgan (JPM) are lead bookrunners on the deal.Founded in 2015, TuSimple is looking to transform the $800 billion trucking industry. The San Diego company, which has plants in Tucson, Shanghai, and Beijing, in addition to operations in Japan, is developing an autonomous freight network for long-haul, semi-trucks that it says will increase efficiency and safety on the road, while cutting operating costs.TuSimple develops software for the Level 4 self-driving, long-haul trucks, which can see up to 1,000 meters away, equivalent to 30 seconds of driving time. High-definition maps provide accuracy within five centimeters.The company is partnering withNavistar(NAV) to develop trucks for the North American market by 2024,its prospectus said. TuSimple has another partnership withVolkswagensubsidiary TRATON for trucks in Europe. Navistar, TRATON, and United Parcel Service (UPS) are all investors.TuSimple has raised $800 million in funding, including a $350 million round in November led by VectoIQ.BlackRock(BR), Fidelity Management & Research Co and Capital Group are in talks to buy up to 10.1 million TuSimple shares at the IPO price, the prospectus said.The company will have 212,263,328 shares outstanding, meaning TuSimple’s market cap could climb to $8.3 billion. TuSimple, however, is not profitable. Losses widened to $177.9 million in 2020 from $84.9 million in 2019. Revenue jumped nearly 160% to $1.8 million in 2020.","news_type":1,"symbols_score_info":{"ALKT":0.9,"APP":0.9,"COIN":0.9,"KRT":0.9,"RPHM":0.9,"TSP":0.9,"VECT":0.9}},"isVote":1,"tweetType":1,"viewCount":652,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346150043,"gmtCreate":1618016439482,"gmtModify":1634295240521,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Good good","listText":"Good good","text":"Good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346150043","repostId":"2126315033","repostType":4,"isVote":1,"tweetType":1,"viewCount":458,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187243511,"gmtCreate":1623756736633,"gmtModify":1634028928989,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"well said","listText":"well said","text":"well said","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/187243511","repostId":"1167457915","repostType":4,"repost":{"id":"1167457915","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1623750756,"share":"https://www.laohu8.com/m/news/1167457915?lang=&edition=full","pubTime":"2021-06-15 17:52","market":"us","language":"en","title":"Novavax Vs. Pfizer Vs. Moderna: How COVID-19 Vaccines Stack Up","url":"https://stock-news.laohu8.com/highlight/detail?id=1167457915","media":"Benzinga","summary":"It was \"better late than never\" for Novavax, Inc.NVAX, as the biopharma finally got around to announ","content":"<p>It was \"better late than never\" for&nbsp;<b>Novavax, Inc.</b>NVAX, as the biopharma finally got around to announcing interim results from the U.S. and Mexico leg of the Phase 3 study of NVX-CoV2371, its vaccine candidate against the novel coronavirus.</p>\n<p>Here's a comparative perspective of the vaccine candidates from Novavax, and the frontrunners, namely<b>Pfizer Inc.</b>PFE 0.05%-<b>BioNTech SE</b>BNTXand<b>Moderna, Inc.</b>MRNA, both of which have authorized vaccines in the market.</p>\n<p><b>Vaccine Type:</b>&nbsp;Novavax's NVX-CoV2371 is a recombinant nano-particle protein-based COVID-19 vaccine that is packaged with the company's proprietary Matrix-M adjuvant.</p>\n<p>The Pfizer-BioNTech and Moderna products are mRNA vaccines, or modern&nbsp;vaccines that work by using a genetic code called mRNA that instructs our immune cells to make spike protein, which is found on the surface of the virus that causes COVID-19.</p>\n<p>This spike protein, though harmless, is capable of triggering our immune system to produce antibodies that offer protection against future infection.</p>\n<p>Novavax's vaccine is a protein adjuvant that contains the spike protein of the coronavirus itself, but formulated as a nanoparticle&nbsp;that cannot cause disease. The injected vaccine then stimulates the immune system to produce antibodies and T-cell immune responses.</p>\n<p><b>The Vaccine Doses:</b>&nbsp;The vaccines from each of the three companies require two doses. Each dose consists of 30 mcg for Pfizer and 100 mcg for Moderna, while for Novavax, each vaccine dose consists of 5 mcg of NVX-CoV2371 and 50 mcg of Matrix-M1 adjuvant that are co-formulated.</p>\n<p>The interval between the two doses —&nbsp;the priming and booster dose —&nbsp;is 21 days each for Pfizer and Novavax and 28 days for Moderna.</p>\n<p><b>The Target Population:</b>&nbsp;The original late-stage trial of Pfizer-BioNTech evaluated the vaccine in participants&nbsp;ages 16 years and older. The trial enrolled 43,448 participants.</p>\n<p>Moderna'sPhase 3 COVE study enrolled 30,000 participants&nbsp;ages 18 years and up.</p>\n<p>Since then, these two companies have obtained authorizations for their respective vaccines to be used in adolescents.</p>\n<p>Bothcompanieshave also initiated studies in the pediatric population.</p>\n<p>Novavax's study enrolled 29,960 participants&nbsp;18 years of age and older&nbsp;across 119 sites in the U.S. and Mexico. The placebo-controlled portion of PREVENT-19 continues in adolescents from 12 to less than 18 years of age and recently completed enrollment with 2,248 participants.</p>\n<p><b>Vaccine Logistics:</b>&nbsp;Pfizer recently secured FDA authorization for storing undiluted, thawed vaccine vials in the refrigerator at 2°C to 8°C for up to one month.</p>\n<p>Previously, thawed, undiluted vaccine vials could be stored in the refrigerator for up to five&nbsp;days. Moderna's vaccine can be stored refrigerated between 2° and 8°C for up to 30 days prior to first use.</p>\n<p>NVX-CoV2373 is stored and stable at 2°- 8°C, allowing the use of existing vaccine supply chain channels for its distribution. It is packaged in a ready-to-use liquid formulation in 10-dose vials.</p>\n<p><b>Vaccine Efficacy:</b>&nbsp;Interim data from Pfizer-BioNTech's Phase 3 trials released in December showed the vaccine was well-tolerated and demonstrated 95% efficacy in preventing COVID-19 in those without prior infection seven&nbsp;days or more after the second dose. Updated top-line results released for up to six months after the second dose confirmed efficacy at 91.3%.</p>\n<p>The vaccine was found 100% effective against severe disease as defined by the U.S. Centers for Disease Control and Prevention, and 95.3% effective against severe COVID-19 as defined by the FDA. It was also proved effective against the U.K. strain in lab studies.</p>\n<p>Moderna's vaccine showed efficacy of 94.1% against COVID-19. The company announced in May initial data from its Phase 2 study showing that a single 50 mcg dose of mRNA-1273 or mRNA-1273.351 given as a booster to previously vaccinated individuals increased neutralizing antibody titer responses against SARS-CoV-2 and two variants of concern, B.1.351, first identified in South Africa, and P.1, first identified in Brazil.</p>\n<p>Novavax's investigational vaccine demonstrated 100% protection against moderate and severe disease not involving variants of concern or variants of interest.</p>\n<p>Against variants of concern and variants of interest, the efficacy was 93.2% and in high-risk populations, defined as over 65 or under 65 years with certain comorbidities or having circumstances with frequent COVID-19 exposure, the efficacy was 91%.</p>\n<p>Overall efficacy was 90.4%, meeting the primary endpoint.</p>\n<p><b>Cantor Fitzgerald On Novavax's Vaccine:</b>A differentiating factor for NVX-2373&nbsp;is that it showed vaccine efficacy of 93.2% against VoC/VoI, which demonstrates protection across a broad range of SARS-CoV-2 strains, Cantor Fitzgerald analyst Charles Duncan said in a Monday morning note.</p>\n<p>\"Overall, these results enhance our conviction for a differentiated clinical and logistics profile from the SARS-CoV-2 vaccine candidate ‘2373,\" the analyst said.</p>\n<p>Showing efficacy against new strains in two Phase 3 clinical trials, rather than extrapolating potential efficacy from a neutralizing antibody assay conducted in a petri dish, differentiates NVX-CoV2373 from other vaccines that have emergency use authorization, he said.</p>\n<p>This profile, according to Cantor reduces regulatory/ commercial risk for the ‘2373 SARS-CoV-2 prophylactic vaccine candidate and, with positive Phase 3 data for NanoFlu reported in March 2020, should raise the profile for Novavax's platform as a whole.</p>\n<p><b>Vaccine Safety Data:</b>Pfizer-BioNTech's vaccine showed a favorable tolerability and safety profile, with the most common adverse events from&nbsp;BNT162b2 being transient, mild to moderate pain at the injection site, fatigue and headache, and these generally resolved within two days.</p>\n<p>For Moderna, the most common adverse reactions included injection site pain, fatigue, myalgia, arthralgia, headache, and erythema/redness at the injection site. Solicited adverse reactions increased in frequency and severity in the mRNA-1273 group after the second dose.</p>\n<p>Preliminary safety data from Novavax's trial showed the vaccine to be generally well-tolerated. Serious and severe adverse events were low in number and balanced between vaccine and placebo groups.</p>\n<p>In assessing reactogenicity seven&nbsp;days after dose one&nbsp;and dose two, injection site pain and tenderness, generally mild to moderate in severity, were the most common local symptoms, lasting less than three days. Fatigue, headache and muscle pain were the most common systemic symptoms, lasting less than two days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Vs. Pfizer Vs. Moderna: How COVID-19 Vaccines Stack Up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Vs. Pfizer Vs. Moderna: How COVID-19 Vaccines Stack Up\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-06-15 17:52</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>It was \"better late than never\" for&nbsp;<b>Novavax, Inc.</b>NVAX, as the biopharma finally got around to announcing interim results from the U.S. and Mexico leg of the Phase 3 study of NVX-CoV2371, its vaccine candidate against the novel coronavirus.</p>\n<p>Here's a comparative perspective of the vaccine candidates from Novavax, and the frontrunners, namely<b>Pfizer Inc.</b>PFE 0.05%-<b>BioNTech SE</b>BNTXand<b>Moderna, Inc.</b>MRNA, both of which have authorized vaccines in the market.</p>\n<p><b>Vaccine Type:</b>&nbsp;Novavax's NVX-CoV2371 is a recombinant nano-particle protein-based COVID-19 vaccine that is packaged with the company's proprietary Matrix-M adjuvant.</p>\n<p>The Pfizer-BioNTech and Moderna products are mRNA vaccines, or modern&nbsp;vaccines that work by using a genetic code called mRNA that instructs our immune cells to make spike protein, which is found on the surface of the virus that causes COVID-19.</p>\n<p>This spike protein, though harmless, is capable of triggering our immune system to produce antibodies that offer protection against future infection.</p>\n<p>Novavax's vaccine is a protein adjuvant that contains the spike protein of the coronavirus itself, but formulated as a nanoparticle&nbsp;that cannot cause disease. The injected vaccine then stimulates the immune system to produce antibodies and T-cell immune responses.</p>\n<p><b>The Vaccine Doses:</b>&nbsp;The vaccines from each of the three companies require two doses. Each dose consists of 30 mcg for Pfizer and 100 mcg for Moderna, while for Novavax, each vaccine dose consists of 5 mcg of NVX-CoV2371 and 50 mcg of Matrix-M1 adjuvant that are co-formulated.</p>\n<p>The interval between the two doses —&nbsp;the priming and booster dose —&nbsp;is 21 days each for Pfizer and Novavax and 28 days for Moderna.</p>\n<p><b>The Target Population:</b>&nbsp;The original late-stage trial of Pfizer-BioNTech evaluated the vaccine in participants&nbsp;ages 16 years and older. The trial enrolled 43,448 participants.</p>\n<p>Moderna'sPhase 3 COVE study enrolled 30,000 participants&nbsp;ages 18 years and up.</p>\n<p>Since then, these two companies have obtained authorizations for their respective vaccines to be used in adolescents.</p>\n<p>Bothcompanieshave also initiated studies in the pediatric population.</p>\n<p>Novavax's study enrolled 29,960 participants&nbsp;18 years of age and older&nbsp;across 119 sites in the U.S. and Mexico. The placebo-controlled portion of PREVENT-19 continues in adolescents from 12 to less than 18 years of age and recently completed enrollment with 2,248 participants.</p>\n<p><b>Vaccine Logistics:</b>&nbsp;Pfizer recently secured FDA authorization for storing undiluted, thawed vaccine vials in the refrigerator at 2°C to 8°C for up to one month.</p>\n<p>Previously, thawed, undiluted vaccine vials could be stored in the refrigerator for up to five&nbsp;days. Moderna's vaccine can be stored refrigerated between 2° and 8°C for up to 30 days prior to first use.</p>\n<p>NVX-CoV2373 is stored and stable at 2°- 8°C, allowing the use of existing vaccine supply chain channels for its distribution. It is packaged in a ready-to-use liquid formulation in 10-dose vials.</p>\n<p><b>Vaccine Efficacy:</b>&nbsp;Interim data from Pfizer-BioNTech's Phase 3 trials released in December showed the vaccine was well-tolerated and demonstrated 95% efficacy in preventing COVID-19 in those without prior infection seven&nbsp;days or more after the second dose. Updated top-line results released for up to six months after the second dose confirmed efficacy at 91.3%.</p>\n<p>The vaccine was found 100% effective against severe disease as defined by the U.S. Centers for Disease Control and Prevention, and 95.3% effective against severe COVID-19 as defined by the FDA. It was also proved effective against the U.K. strain in lab studies.</p>\n<p>Moderna's vaccine showed efficacy of 94.1% against COVID-19. The company announced in May initial data from its Phase 2 study showing that a single 50 mcg dose of mRNA-1273 or mRNA-1273.351 given as a booster to previously vaccinated individuals increased neutralizing antibody titer responses against SARS-CoV-2 and two variants of concern, B.1.351, first identified in South Africa, and P.1, first identified in Brazil.</p>\n<p>Novavax's investigational vaccine demonstrated 100% protection against moderate and severe disease not involving variants of concern or variants of interest.</p>\n<p>Against variants of concern and variants of interest, the efficacy was 93.2% and in high-risk populations, defined as over 65 or under 65 years with certain comorbidities or having circumstances with frequent COVID-19 exposure, the efficacy was 91%.</p>\n<p>Overall efficacy was 90.4%, meeting the primary endpoint.</p>\n<p><b>Cantor Fitzgerald On Novavax's Vaccine:</b>A differentiating factor for NVX-2373&nbsp;is that it showed vaccine efficacy of 93.2% against VoC/VoI, which demonstrates protection across a broad range of SARS-CoV-2 strains, Cantor Fitzgerald analyst Charles Duncan said in a Monday morning note.</p>\n<p>\"Overall, these results enhance our conviction for a differentiated clinical and logistics profile from the SARS-CoV-2 vaccine candidate ‘2373,\" the analyst said.</p>\n<p>Showing efficacy against new strains in two Phase 3 clinical trials, rather than extrapolating potential efficacy from a neutralizing antibody assay conducted in a petri dish, differentiates NVX-CoV2373 from other vaccines that have emergency use authorization, he said.</p>\n<p>This profile, according to Cantor reduces regulatory/ commercial risk for the ‘2373 SARS-CoV-2 prophylactic vaccine candidate and, with positive Phase 3 data for NanoFlu reported in March 2020, should raise the profile for Novavax's platform as a whole.</p>\n<p><b>Vaccine Safety Data:</b>Pfizer-BioNTech's vaccine showed a favorable tolerability and safety profile, with the most common adverse events from&nbsp;BNT162b2 being transient, mild to moderate pain at the injection site, fatigue and headache, and these generally resolved within two days.</p>\n<p>For Moderna, the most common adverse reactions included injection site pain, fatigue, myalgia, arthralgia, headache, and erythema/redness at the injection site. Solicited adverse reactions increased in frequency and severity in the mRNA-1273 group after the second dose.</p>\n<p>Preliminary safety data from Novavax's trial showed the vaccine to be generally well-tolerated. Serious and severe adverse events were low in number and balanced between vaccine and placebo groups.</p>\n<p>In assessing reactogenicity seven&nbsp;days after dose one&nbsp;and dose two, injection site pain and tenderness, generally mild to moderate in severity, were the most common local symptoms, lasting less than three days. Fatigue, headache and muscle pain were the most common systemic symptoms, lasting less than two days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167457915","content_text":"It was \"better late than never\" for Novavax, Inc.NVAX, as the biopharma finally got around to announcing interim results from the U.S. and Mexico leg of the Phase 3 study of NVX-CoV2371, its vaccine candidate against the novel coronavirus.\nHere's a comparative perspective of the vaccine candidates from Novavax, and the frontrunners, namelyPfizer Inc.PFE 0.05%-BioNTech SEBNTXandModerna, Inc.MRNA, both of which have authorized vaccines in the market.\nVaccine Type: Novavax's NVX-CoV2371 is a recombinant nano-particle protein-based COVID-19 vaccine that is packaged with the company's proprietary Matrix-M adjuvant.\nThe Pfizer-BioNTech and Moderna products are mRNA vaccines, or modern vaccines that work by using a genetic code called mRNA that instructs our immune cells to make spike protein, which is found on the surface of the virus that causes COVID-19.\nThis spike protein, though harmless, is capable of triggering our immune system to produce antibodies that offer protection against future infection.\nNovavax's vaccine is a protein adjuvant that contains the spike protein of the coronavirus itself, but formulated as a nanoparticle that cannot cause disease. The injected vaccine then stimulates the immune system to produce antibodies and T-cell immune responses.\nThe Vaccine Doses: The vaccines from each of the three companies require two doses. Each dose consists of 30 mcg for Pfizer and 100 mcg for Moderna, while for Novavax, each vaccine dose consists of 5 mcg of NVX-CoV2371 and 50 mcg of Matrix-M1 adjuvant that are co-formulated.\nThe interval between the two doses — the priming and booster dose — is 21 days each for Pfizer and Novavax and 28 days for Moderna.\nThe Target Population: The original late-stage trial of Pfizer-BioNTech evaluated the vaccine in participants ages 16 years and older. The trial enrolled 43,448 participants.\nModerna'sPhase 3 COVE study enrolled 30,000 participants ages 18 years and up.\nSince then, these two companies have obtained authorizations for their respective vaccines to be used in adolescents.\nBothcompanieshave also initiated studies in the pediatric population.\nNovavax's study enrolled 29,960 participants 18 years of age and older across 119 sites in the U.S. and Mexico. The placebo-controlled portion of PREVENT-19 continues in adolescents from 12 to less than 18 years of age and recently completed enrollment with 2,248 participants.\nVaccine Logistics: Pfizer recently secured FDA authorization for storing undiluted, thawed vaccine vials in the refrigerator at 2°C to 8°C for up to one month.\nPreviously, thawed, undiluted vaccine vials could be stored in the refrigerator for up to five days. Moderna's vaccine can be stored refrigerated between 2° and 8°C for up to 30 days prior to first use.\nNVX-CoV2373 is stored and stable at 2°- 8°C, allowing the use of existing vaccine supply chain channels for its distribution. It is packaged in a ready-to-use liquid formulation in 10-dose vials.\nVaccine Efficacy: Interim data from Pfizer-BioNTech's Phase 3 trials released in December showed the vaccine was well-tolerated and demonstrated 95% efficacy in preventing COVID-19 in those without prior infection seven days or more after the second dose. Updated top-line results released for up to six months after the second dose confirmed efficacy at 91.3%.\nThe vaccine was found 100% effective against severe disease as defined by the U.S. Centers for Disease Control and Prevention, and 95.3% effective against severe COVID-19 as defined by the FDA. It was also proved effective against the U.K. strain in lab studies.\nModerna's vaccine showed efficacy of 94.1% against COVID-19. The company announced in May initial data from its Phase 2 study showing that a single 50 mcg dose of mRNA-1273 or mRNA-1273.351 given as a booster to previously vaccinated individuals increased neutralizing antibody titer responses against SARS-CoV-2 and two variants of concern, B.1.351, first identified in South Africa, and P.1, first identified in Brazil.\nNovavax's investigational vaccine demonstrated 100% protection against moderate and severe disease not involving variants of concern or variants of interest.\nAgainst variants of concern and variants of interest, the efficacy was 93.2% and in high-risk populations, defined as over 65 or under 65 years with certain comorbidities or having circumstances with frequent COVID-19 exposure, the efficacy was 91%.\nOverall efficacy was 90.4%, meeting the primary endpoint.\nCantor Fitzgerald On Novavax's Vaccine:A differentiating factor for NVX-2373 is that it showed vaccine efficacy of 93.2% against VoC/VoI, which demonstrates protection across a broad range of SARS-CoV-2 strains, Cantor Fitzgerald analyst Charles Duncan said in a Monday morning note.\n\"Overall, these results enhance our conviction for a differentiated clinical and logistics profile from the SARS-CoV-2 vaccine candidate ‘2373,\" the analyst said.\nShowing efficacy against new strains in two Phase 3 clinical trials, rather than extrapolating potential efficacy from a neutralizing antibody assay conducted in a petri dish, differentiates NVX-CoV2373 from other vaccines that have emergency use authorization, he said.\nThis profile, according to Cantor reduces regulatory/ commercial risk for the ‘2373 SARS-CoV-2 prophylactic vaccine candidate and, with positive Phase 3 data for NanoFlu reported in March 2020, should raise the profile for Novavax's platform as a whole.\nVaccine Safety Data:Pfizer-BioNTech's vaccine showed a favorable tolerability and safety profile, with the most common adverse events from BNT162b2 being transient, mild to moderate pain at the injection site, fatigue and headache, and these generally resolved within two days.\nFor Moderna, the most common adverse reactions included injection site pain, fatigue, myalgia, arthralgia, headache, and erythema/redness at the injection site. Solicited adverse reactions increased in frequency and severity in the mRNA-1273 group after the second dose.\nPreliminary safety data from Novavax's trial showed the vaccine to be generally well-tolerated. Serious and severe adverse events were low in number and balanced between vaccine and placebo groups.\nIn assessing reactogenicity seven days after dose one and dose two, injection site pain and tenderness, generally mild to moderate in severity, were the most common local symptoms, lasting less than three days. Fatigue, headache and muscle pain were the most common systemic symptoms, lasting less than two days.","news_type":1,"symbols_score_info":{"MRNA":0.9,"NVAX":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1572,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345236635,"gmtCreate":1618316988927,"gmtModify":1634293770169,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Patience&nbsp;","listText":"Patience&nbsp;","text":"Patience","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/345236635","repostId":"1178797310","repostType":4,"repost":{"id":"1178797310","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1618312466,"share":"https://www.laohu8.com/m/news/1178797310?lang=&edition=full","pubTime":"2021-04-13 19:14","market":"us","language":"en","title":"Johnson & Johnson dipped about 3% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1178797310","media":"Tiger Newspress","summary":"U.S. Calls For Pause On Johnson & Johnson Vaccine After Clotting Cases.KEY POINTSThe FDA said it is ","content":"<p>U.S. Calls For Pause On Johnson &amp; Johnson Vaccine After Clotting Cases.</p><p><img src=\"https://static.tigerbbs.com/44ed5a479ba7fa5976bb70090ba50c81\" tg-width=\"1242\" tg-height=\"2148\" referrerpolicy=\"no-referrer\"></p><p><b>KEY POINTS</b></p><ul><li>The FDA said it is asking states to temporarily halt using J&amp;J’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.</li><li>The FDA said the recommendation is “out of an abundance of caution.”</li><li>All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot.</li></ul><p>The Food and Drug Administration said Tuesday it is asking states to temporarily halt usingJohnson &amp; Johnson’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.</p><p>The FDA said the recommendation is “out of an abundance of caution.”</p><p>“Right now, these adverse events appear to be extremely rare,” the FDA said in a joint statement with the Centers for Disease Control and Prevention. “COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously.”</p><p><img src=\"https://static.tigerbbs.com/b4808bfed9dcd9d1cc27ef92e3ba3dcf\" tg-width=\"512\" tg-height=\"232\">A White House spokesman referred CNBC to HHS when asked for comment.</p><p>All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot. Doctors typically treat that type of blood clot with heparin but health regulators noted that could be dangerous in this case and recommended a different treatment.</p><p>J&amp;J said in a statement that “no clear causal relationship” has been identified between the blood clots and the vaccine, adding it is working closely with regulators to assess the data.</p><p>People who receive the vaccine and “develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider,” the FDA and CDC said.</p><p>Shares of J&amp;J were down more than 3% in premarket trading Tuesday.</p><p>The CDC will convene a meeting of the Advisory Committee on Immunization Practices on Wednesday to further review the cases, federal health regulators said Tuesday. The FDA is also investigating the cases.</p><p>J&amp;J’s Covid-19 vaccine, like Pfizer’s and Moderna’s shots, received emergency use authorization from the FDA to start distributing the doses across the U.S. An EUA grants conditional clearance based on two months of safety data, pending full approval which usually requires at least six months of data.</p><p>When J&amp;J submitted its Covid vaccine data to the FDA in February, no specific concerns were identified when analyzed by age, race and comorbidities, according to the agency. The FDA said at the time the most common side effects reported were headache and fatigue, followed by muscle aches, nausea and fever.</p><p>The New York Timesfirst reportedthe news.</p><p>It’s unclear how the pause will impact J&amp;J’s goal to deliver 100 million doses to the U.S. by the end of May. The company has already been plagued by manufacturing issues of its vaccine.</p><p>Last week, Europe’s medicines regulatorsaid it found a possible linkbetween the coronavirus vaccine developed by AstraZeneca and the University of Oxford and rare blood clotting issues. AstraZeneca has not received authorization for use in the U.S.</p><p>Emer Cooke, executive director of the European Medicines Agency, said in a televised news conference last week that unusual blood clotting with low blood platelets would be added as a “very rare” side effect to the vaccine’s product information, along with a slew of other possible adverse reactions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Johnson & Johnson dipped about 3% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJohnson & Johnson dipped about 3% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-04-13 19:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. Calls For Pause On Johnson &amp; Johnson Vaccine After Clotting Cases.</p><p><img src=\"https://static.tigerbbs.com/44ed5a479ba7fa5976bb70090ba50c81\" tg-width=\"1242\" tg-height=\"2148\" referrerpolicy=\"no-referrer\"></p><p><b>KEY POINTS</b></p><ul><li>The FDA said it is asking states to temporarily halt using J&amp;J’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.</li><li>The FDA said the recommendation is “out of an abundance of caution.”</li><li>All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot.</li></ul><p>The Food and Drug Administration said Tuesday it is asking states to temporarily halt usingJohnson &amp; Johnson’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.</p><p>The FDA said the recommendation is “out of an abundance of caution.”</p><p>“Right now, these adverse events appear to be extremely rare,” the FDA said in a joint statement with the Centers for Disease Control and Prevention. “COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously.”</p><p><img src=\"https://static.tigerbbs.com/b4808bfed9dcd9d1cc27ef92e3ba3dcf\" tg-width=\"512\" tg-height=\"232\">A White House spokesman referred CNBC to HHS when asked for comment.</p><p>All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot. Doctors typically treat that type of blood clot with heparin but health regulators noted that could be dangerous in this case and recommended a different treatment.</p><p>J&amp;J said in a statement that “no clear causal relationship” has been identified between the blood clots and the vaccine, adding it is working closely with regulators to assess the data.</p><p>People who receive the vaccine and “develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider,” the FDA and CDC said.</p><p>Shares of J&amp;J were down more than 3% in premarket trading Tuesday.</p><p>The CDC will convene a meeting of the Advisory Committee on Immunization Practices on Wednesday to further review the cases, federal health regulators said Tuesday. The FDA is also investigating the cases.</p><p>J&amp;J’s Covid-19 vaccine, like Pfizer’s and Moderna’s shots, received emergency use authorization from the FDA to start distributing the doses across the U.S. An EUA grants conditional clearance based on two months of safety data, pending full approval which usually requires at least six months of data.</p><p>When J&amp;J submitted its Covid vaccine data to the FDA in February, no specific concerns were identified when analyzed by age, race and comorbidities, according to the agency. The FDA said at the time the most common side effects reported were headache and fatigue, followed by muscle aches, nausea and fever.</p><p>The New York Timesfirst reportedthe news.</p><p>It’s unclear how the pause will impact J&amp;J’s goal to deliver 100 million doses to the U.S. by the end of May. The company has already been plagued by manufacturing issues of its vaccine.</p><p>Last week, Europe’s medicines regulatorsaid it found a possible linkbetween the coronavirus vaccine developed by AstraZeneca and the University of Oxford and rare blood clotting issues. AstraZeneca has not received authorization for use in the U.S.</p><p>Emer Cooke, executive director of the European Medicines Agency, said in a televised news conference last week that unusual blood clotting with low blood platelets would be added as a “very rare” side effect to the vaccine’s product information, along with a slew of other possible adverse reactions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178797310","content_text":"U.S. Calls For Pause On Johnson & Johnson Vaccine After Clotting Cases.KEY POINTSThe FDA said it is asking states to temporarily halt using J&J’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.The FDA said the recommendation is “out of an abundance of caution.”All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot.The Food and Drug Administration said Tuesday it is asking states to temporarily halt usingJohnson & Johnson’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.The FDA said the recommendation is “out of an abundance of caution.”“Right now, these adverse events appear to be extremely rare,” the FDA said in a joint statement with the Centers for Disease Control and Prevention. “COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously.”A White House spokesman referred CNBC to HHS when asked for comment.All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot. Doctors typically treat that type of blood clot with heparin but health regulators noted that could be dangerous in this case and recommended a different treatment.J&J said in a statement that “no clear causal relationship” has been identified between the blood clots and the vaccine, adding it is working closely with regulators to assess the data.People who receive the vaccine and “develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider,” the FDA and CDC said.Shares of J&J were down more than 3% in premarket trading Tuesday.The CDC will convene a meeting of the Advisory Committee on Immunization Practices on Wednesday to further review the cases, federal health regulators said Tuesday. The FDA is also investigating the cases.J&J’s Covid-19 vaccine, like Pfizer’s and Moderna’s shots, received emergency use authorization from the FDA to start distributing the doses across the U.S. An EUA grants conditional clearance based on two months of safety data, pending full approval which usually requires at least six months of data.When J&J submitted its Covid vaccine data to the FDA in February, no specific concerns were identified when analyzed by age, race and comorbidities, according to the agency. The FDA said at the time the most common side effects reported were headache and fatigue, followed by muscle aches, nausea and fever.The New York Timesfirst reportedthe news.It’s unclear how the pause will impact J&J’s goal to deliver 100 million doses to the U.S. by the end of May. The company has already been plagued by manufacturing issues of its vaccine.Last week, Europe’s medicines regulatorsaid it found a possible linkbetween the coronavirus vaccine developed by AstraZeneca and the University of Oxford and rare blood clotting issues. AstraZeneca has not received authorization for use in the U.S.Emer Cooke, executive director of the European Medicines Agency, said in a televised news conference last week that unusual blood clotting with low blood platelets would be added as a “very rare” side effect to the vaccine’s product information, along with a slew of other possible adverse reactions.","news_type":1,"symbols_score_info":{"JNJ":0.9}},"isVote":1,"tweetType":1,"viewCount":1390,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346150386,"gmtCreate":1618016472245,"gmtModify":1634295240401,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Ah.....","listText":"Ah.....","text":"Ah.....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/346150386","repostId":"1180128899","repostType":4,"isVote":1,"tweetType":1,"viewCount":560,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":327405089,"gmtCreate":1616114513941,"gmtModify":1631887137495,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/Z74.SI\">$SINGTEL(Z74.SI)$</a>GoGoGo!","listText":"<a href=\"https://laohu8.com/S/Z74.SI\">$SINGTEL(Z74.SI)$</a>GoGoGo!","text":"$SINGTEL(Z74.SI)$GoGoGo!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/327405089","isVote":1,"tweetType":1,"viewCount":376,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187248023,"gmtCreate":1623756784062,"gmtModify":1634028927678,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Wait wait wait","listText":"Wait wait wait","text":"Wait wait wait","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/187248023","repostId":"1193728447","repostType":4,"isVote":1,"tweetType":1,"viewCount":1247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":341738313,"gmtCreate":1617854551332,"gmtModify":1631885601578,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>flying high","listText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>flying high","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$flying high","images":[{"img":"https://static.tigerbbs.com/b356d89514cfab9d10944ac60a98b11a","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/341738313","isVote":1,"tweetType":1,"viewCount":331,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":350937081,"gmtCreate":1616147849643,"gmtModify":1634527003256,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Long run stock","listText":"Long run stock","text":"Long run stock","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/350937081","repostId":"1105114263","repostType":4,"repost":{"id":"1105114263","kind":"news","pubTimestamp":1616140761,"share":"https://www.laohu8.com/m/news/1105114263?lang=&edition=full","pubTime":"2021-03-19 15:59","market":"us","language":"en","title":"Bank Stocks Are Rallying. Here's Why.","url":"https://stock-news.laohu8.com/highlight/detail?id=1105114263","media":"Barrons","summary":"In a down day for much of the market, bank stocks emerged as one of the few bright spots. That’s a t","content":"<p>In a down day for much of the market, bank stocks emerged as one of the few bright spots. That’s a trend that is likely to continue if the yield on the 10-year note continues to climb.</p>\n<p>Shortly after Thursday’s market open, the&nbsp;SPDR S&amp;P Bank&nbsp;exchange-traded fund (ticker: KBE) was up 2.8%, outpacing the 0.5% drop in the&nbsp;S&amp;P 500&nbsp;and the 1.5% decline in the&nbsp;Nasdaq Composite.The rally in banks comes as the yield on the 10-year Treasury note hit 1.75% early Thursday — its highest level in more than a year. As bond yields rise, growth stocks —which include many of the tech names that fared well during the pandemic— tend to suffer as the value of their future cash flows wane.</p>\n<p>Bank stocks, which were depressed for much of the last year, are one of the few beneficiaries of the jump in long-term yields. The sector, which was hammered after the&nbsp;Federal Reserve lowered interest rates to near-zero last year, benefits when rates rise. Banks lend money on the long end of the yield curve and borrow on the short end of the curve. Even with interest rates still low by historical standards,any steepening of the yield curve&nbsp;is a welcome sign for banks as they make their money on the spread between loans and deposits.</p>\n<p>With economists expecting that the economic recovery from the coronavirus pandemic will be quicker than initially feared, bank stocks should be poised to continue to outperform the broader market. So far this year, the SPDR S&amp;P Bank ETF has gained 33%, while the S&amp;P 500 is up nearly 6%.</p>\n<p>Among the banks leading the sector’s rally on Thursday were&nbsp;Bank of America(BAC), which was up 2.6% and&nbsp;Wells Fargo(WFC), which gained 2.4%.JPMorgan Chase (JPM) and&nbsp;HSBC(HSBC)&nbsp;were up more than 1%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title> Bank Stocks Are Rallying. Here's Why.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n Bank Stocks Are Rallying. Here's Why.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-19 15:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/why-bank-stocks-are-rallying-and-why-they-can-continue-to-do-so-51616079455?mod=RTA><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In a down day for much of the market, bank stocks emerged as one of the few bright spots. That’s a trend that is likely to continue if the yield on the 10-year note continues to climb.\nShortly after ...</p>\n\n<a href=\"https://www.barrons.com/articles/why-bank-stocks-are-rallying-and-why-they-can-continue-to-do-so-51616079455?mod=RTA\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KBE":"银行指数ETF-SPDR KBW","BAC":"美国银行","WFC":"富国银行","CFG":"Citizens Financial Group","ZION":"齐昂银行"},"source_url":"https://www.barrons.com/articles/why-bank-stocks-are-rallying-and-why-they-can-continue-to-do-so-51616079455?mod=RTA","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105114263","content_text":"In a down day for much of the market, bank stocks emerged as one of the few bright spots. That’s a trend that is likely to continue if the yield on the 10-year note continues to climb.\nShortly after Thursday’s market open, the SPDR S&P Bank exchange-traded fund (ticker: KBE) was up 2.8%, outpacing the 0.5% drop in the S&P 500 and the 1.5% decline in the Nasdaq Composite.The rally in banks comes as the yield on the 10-year Treasury note hit 1.75% early Thursday — its highest level in more than a year. As bond yields rise, growth stocks —which include many of the tech names that fared well during the pandemic— tend to suffer as the value of their future cash flows wane.\nBank stocks, which were depressed for much of the last year, are one of the few beneficiaries of the jump in long-term yields. The sector, which was hammered after the Federal Reserve lowered interest rates to near-zero last year, benefits when rates rise. Banks lend money on the long end of the yield curve and borrow on the short end of the curve. Even with interest rates still low by historical standards,any steepening of the yield curve is a welcome sign for banks as they make their money on the spread between loans and deposits.\nWith economists expecting that the economic recovery from the coronavirus pandemic will be quicker than initially feared, bank stocks should be poised to continue to outperform the broader market. So far this year, the SPDR S&P Bank ETF has gained 33%, while the S&P 500 is up nearly 6%.\nAmong the banks leading the sector’s rally on Thursday were Bank of America(BAC), which was up 2.6% and Wells Fargo(WFC), which gained 2.4%.JPMorgan Chase (JPM) and HSBC(HSBC) were up more than 1%.","news_type":1,"symbols_score_info":{"BAC":0.9,"CFG":0.9,"KBE":0.9,"WFC":0.9,"ZION":0.9}},"isVote":1,"tweetType":1,"viewCount":200,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185737575,"gmtCreate":1623672919397,"gmtModify":1634030304131,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"SS ???","listText":"SS ???","text":"SS ???","images":[{"img":"https://static.tigerbbs.com/6f51967c7d0800938abf4d9b95e60af8","width":"1080","height":"2650"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/185737575","isVote":1,"tweetType":1,"viewCount":1972,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":110434977,"gmtCreate":1622479080999,"gmtModify":1634101194889,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/110434977","repostId":"1112383458","repostType":2,"isVote":1,"tweetType":1,"viewCount":982,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":342045142,"gmtCreate":1618138483986,"gmtModify":1634294731867,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/342045142","repostId":"2126035617","repostType":2,"isVote":1,"tweetType":1,"viewCount":1443,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":342045957,"gmtCreate":1618138456579,"gmtModify":1634294732109,"author":{"id":"3578819471059082","authorId":"3578819471059082","name":"TerenceWon","avatar":"https://static.tigerbbs.com/5786c079dea543ebea1a04545c8387b9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578819471059082","authorIdStr":"3578819471059082"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/342045957","repostId":"2126032195","repostType":2,"isVote":1,"tweetType":1,"viewCount":839,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}